{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import json\n",
    "from langchain.schema import Document\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from langchain_community.vectorstores import Chroma\n",
    "from langchain_ollama import OllamaEmbeddings  # Ollama embeddings class\n",
    "\n",
    "# Directory containing JSON files\n",
    "DATA_DIR = \"./datasets/microlabs_usa\"\n",
    "\n",
    "# Read JSON files and convert to LangChain documents\n",
    "def load_json_to_documents(data_dir):\n",
    "    docs = []\n",
    "    for file_name in os.listdir(data_dir):\n",
    "        if file_name.endswith(\".json\"):\n",
    "            file_path = os.path.join(data_dir, file_name)\n",
    "            with open(file_path, \"r\") as f:\n",
    "                json_data = json.load(f)\n",
    "                drug_name = file_name.replace(\".json\", \"\")  # Extract drug name from filename\n",
    "                \n",
    "                # Iterate over the keys in the JSON\n",
    "                for key, value in json_data.items():\n",
    "                    # Combine drug name, key name, and content\n",
    "                    chunk_content = f\"Drug Name: {drug_name}\\nKey: {key}\\nContent:\\n{value}\"\n",
    "                    metadata = {\"source\": file_name, \"drug_name\": drug_name, \"key\": key}\n",
    "                    docs.append(Document(page_content=chunk_content, metadata=metadata))\n",
    "    return docs\n",
    "\n",
    "# Load JSON files as documents\n",
    "docs_list = load_json_to_documents(DATA_DIR)\n",
    "\n",
    "# Initialize the text splitter\n",
    "text_splitter = RecursiveCharacterTextSplitter.from_tiktoken_encoder(\n",
    "    chunk_size=800, chunk_overlap=150\n",
    ")\n",
    "\n",
    "# Split documents into smaller chunks\n",
    "doc_splits = text_splitter.split_documents(docs_list)\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "19875"
      ]
     },
     "execution_count": 11,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(doc_splits)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 18,
   "metadata": {},
   "outputs": [
    {
     "ename": "KeyboardInterrupt",
     "evalue": "",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m                         Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[18], line 4\u001b[0m\n\u001b[1;32m      1\u001b[0m embd \u001b[38;5;241m=\u001b[39m OllamaEmbeddings(model\u001b[38;5;241m=\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mnomic-embed-text\u001b[39m\u001b[38;5;124m\"\u001b[39m)  \u001b[38;5;66;03m# You can specify a model like llama-2-7b-chat\u001b[39;00m\n\u001b[1;32m      3\u001b[0m \u001b[38;5;66;03m# Add to Chroma vectorstore\u001b[39;00m\n\u001b[0;32m----> 4\u001b[0m vectorstore \u001b[38;5;241m=\u001b[39m \u001b[43mChroma\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mfrom_documents\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m      5\u001b[0m \u001b[43m    \u001b[49m\u001b[43mdocuments\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mdoc_splits\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m      6\u001b[0m \u001b[43m    \u001b[49m\u001b[43mcollection_name\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43mrag-chroma\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[1;32m      7\u001b[0m \u001b[43m    \u001b[49m\u001b[43membedding\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43membd\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m      8\u001b[0m \u001b[43m    \u001b[49m\u001b[43mpersist_directory\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\u001b[38;5;124;43m./db2\u001b[39;49m\u001b[38;5;124;43m\"\u001b[39;49m\n\u001b[1;32m      9\u001b[0m \u001b[43m)\u001b[49m\n\u001b[1;32m     11\u001b[0m \u001b[38;5;66;03m# Create retriever for question-answering tasks\u001b[39;00m\n\u001b[1;32m     12\u001b[0m retriever \u001b[38;5;241m=\u001b[39m vectorstore\u001b[38;5;241m.\u001b[39mas_retriever()\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/langchain_community/vectorstores/chroma.py:887\u001b[0m, in \u001b[0;36mChroma.from_documents\u001b[0;34m(cls, documents, embedding, ids, collection_name, persist_directory, client_settings, client, collection_metadata, **kwargs)\u001b[0m\n\u001b[1;32m    885\u001b[0m texts \u001b[38;5;241m=\u001b[39m [doc\u001b[38;5;241m.\u001b[39mpage_content \u001b[38;5;28;01mfor\u001b[39;00m doc \u001b[38;5;129;01min\u001b[39;00m documents]\n\u001b[1;32m    886\u001b[0m metadatas \u001b[38;5;241m=\u001b[39m [doc\u001b[38;5;241m.\u001b[39mmetadata \u001b[38;5;28;01mfor\u001b[39;00m doc \u001b[38;5;129;01min\u001b[39;00m documents]\n\u001b[0;32m--> 887\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mcls\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mfrom_texts\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    888\u001b[0m \u001b[43m    \u001b[49m\u001b[43mtexts\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtexts\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    889\u001b[0m \u001b[43m    \u001b[49m\u001b[43membedding\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43membedding\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    890\u001b[0m \u001b[43m    \u001b[49m\u001b[43mmetadatas\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mmetadatas\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    891\u001b[0m \u001b[43m    \u001b[49m\u001b[43mids\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mids\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    892\u001b[0m \u001b[43m    \u001b[49m\u001b[43mcollection_name\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mcollection_name\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    893\u001b[0m \u001b[43m    \u001b[49m\u001b[43mpersist_directory\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mpersist_directory\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    894\u001b[0m \u001b[43m    \u001b[49m\u001b[43mclient_settings\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mclient_settings\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    895\u001b[0m \u001b[43m    \u001b[49m\u001b[43mclient\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mclient\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    896\u001b[0m \u001b[43m    \u001b[49m\u001b[43mcollection_metadata\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mcollection_metadata\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    897\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    898\u001b[0m \u001b[43m\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/langchain_community/vectorstores/chroma.py:843\u001b[0m, in \u001b[0;36mChroma.from_texts\u001b[0;34m(cls, texts, embedding, metadatas, ids, collection_name, persist_directory, client_settings, client, collection_metadata, **kwargs)\u001b[0m\n\u001b[1;32m    835\u001b[0m     \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;21;01mchromadb\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mutils\u001b[39;00m\u001b[38;5;21;01m.\u001b[39;00m\u001b[38;5;21;01mbatch_utils\u001b[39;00m \u001b[38;5;28;01mimport\u001b[39;00m create_batches\n\u001b[1;32m    837\u001b[0m     \u001b[38;5;28;01mfor\u001b[39;00m batch \u001b[38;5;129;01min\u001b[39;00m create_batches(\n\u001b[1;32m    838\u001b[0m         api\u001b[38;5;241m=\u001b[39mchroma_collection\u001b[38;5;241m.\u001b[39m_client,  \u001b[38;5;66;03m# type: ignore[has-type]\u001b[39;00m\n\u001b[1;32m    839\u001b[0m         ids\u001b[38;5;241m=\u001b[39mids,\n\u001b[1;32m    840\u001b[0m         metadatas\u001b[38;5;241m=\u001b[39mmetadatas,  \u001b[38;5;66;03m# type: ignore[arg-type]\u001b[39;00m\n\u001b[1;32m    841\u001b[0m         documents\u001b[38;5;241m=\u001b[39mtexts,\n\u001b[1;32m    842\u001b[0m     ):\n\u001b[0;32m--> 843\u001b[0m         \u001b[43mchroma_collection\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43madd_texts\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    844\u001b[0m \u001b[43m            \u001b[49m\u001b[43mtexts\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mbatch\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;241;43m3\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mif\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mbatch\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;241;43m3\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01melse\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43m[\u001b[49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    845\u001b[0m \u001b[43m            \u001b[49m\u001b[43mmetadatas\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mbatch\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;241;43m2\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mif\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[43mbatch\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;241;43m2\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;28;43;01melse\u001b[39;49;00m\u001b[43m \u001b[49m\u001b[38;5;28;43;01mNone\u001b[39;49;00m\u001b[43m,\u001b[49m\u001b[43m  \u001b[49m\u001b[38;5;66;43;03m# type: ignore[arg-type]\u001b[39;49;00m\n\u001b[1;32m    846\u001b[0m \u001b[43m            \u001b[49m\u001b[43mids\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mbatch\u001b[49m\u001b[43m[\u001b[49m\u001b[38;5;241;43m0\u001b[39;49m\u001b[43m]\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    847\u001b[0m \u001b[43m        \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    848\u001b[0m \u001b[38;5;28;01melse\u001b[39;00m:\n\u001b[1;32m    849\u001b[0m     chroma_collection\u001b[38;5;241m.\u001b[39madd_texts(texts\u001b[38;5;241m=\u001b[39mtexts, metadatas\u001b[38;5;241m=\u001b[39mmetadatas, ids\u001b[38;5;241m=\u001b[39mids)\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/langchain_community/vectorstores/chroma.py:277\u001b[0m, in \u001b[0;36mChroma.add_texts\u001b[0;34m(self, texts, metadatas, ids, **kwargs)\u001b[0m\n\u001b[1;32m    275\u001b[0m texts \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mlist\u001b[39m(texts)\n\u001b[1;32m    276\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_embedding_function \u001b[38;5;129;01mis\u001b[39;00m \u001b[38;5;129;01mnot\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m:\n\u001b[0;32m--> 277\u001b[0m     embeddings \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_embedding_function\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43membed_documents\u001b[49m\u001b[43m(\u001b[49m\u001b[43mtexts\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    278\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m metadatas:\n\u001b[1;32m    279\u001b[0m     \u001b[38;5;66;03m# fill metadatas with empty dicts if somebody\u001b[39;00m\n\u001b[1;32m    280\u001b[0m     \u001b[38;5;66;03m# did not specify metadata for all texts\u001b[39;00m\n\u001b[1;32m    281\u001b[0m     length_diff \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mlen\u001b[39m(texts) \u001b[38;5;241m-\u001b[39m \u001b[38;5;28mlen\u001b[39m(metadatas)\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/langchain_ollama/embeddings.py:161\u001b[0m, in \u001b[0;36mOllamaEmbeddings.embed_documents\u001b[0;34m(self, texts)\u001b[0m\n\u001b[1;32m    159\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21membed_documents\u001b[39m(\u001b[38;5;28mself\u001b[39m, texts: List[\u001b[38;5;28mstr\u001b[39m]) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m List[List[\u001b[38;5;28mfloat\u001b[39m]]:\n\u001b[1;32m    160\u001b[0m \u001b[38;5;250m    \u001b[39m\u001b[38;5;124;03m\"\"\"Embed search docs.\"\"\"\u001b[39;00m\n\u001b[0;32m--> 161\u001b[0m     embedded_docs \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_client\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43membed\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mmodel\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtexts\u001b[49m\u001b[43m)\u001b[49m[\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124membeddings\u001b[39m\u001b[38;5;124m\"\u001b[39m]\n\u001b[1;32m    162\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m embedded_docs\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/ollama/_client.py:355\u001b[0m, in \u001b[0;36mClient.embed\u001b[0;34m(self, model, input, truncate, options, keep_alive)\u001b[0m\n\u001b[1;32m    347\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21membed\u001b[39m(\n\u001b[1;32m    348\u001b[0m   \u001b[38;5;28mself\u001b[39m,\n\u001b[1;32m    349\u001b[0m   model: \u001b[38;5;28mstr\u001b[39m \u001b[38;5;241m=\u001b[39m \u001b[38;5;124m'\u001b[39m\u001b[38;5;124m'\u001b[39m,\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    353\u001b[0m   keep_alive: Optional[Union[\u001b[38;5;28mfloat\u001b[39m, \u001b[38;5;28mstr\u001b[39m]] \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mNone\u001b[39;00m,\n\u001b[1;32m    354\u001b[0m ) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m EmbedResponse:\n\u001b[0;32m--> 355\u001b[0m   \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_request\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    356\u001b[0m \u001b[43m    \u001b[49m\u001b[43mEmbedResponse\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    357\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43mPOST\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[1;32m    358\u001b[0m \u001b[43m    \u001b[49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[38;5;124;43m/api/embed\u001b[39;49m\u001b[38;5;124;43m'\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[1;32m    359\u001b[0m \u001b[43m    \u001b[49m\u001b[43mjson\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mEmbedRequest\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    360\u001b[0m \u001b[43m      \u001b[49m\u001b[43mmodel\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mmodel\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    361\u001b[0m \u001b[43m      \u001b[49m\u001b[38;5;28;43minput\u001b[39;49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43minput\u001b[39;49m\u001b[43m,\u001b[49m\n\u001b[1;32m    362\u001b[0m \u001b[43m      \u001b[49m\u001b[43mtruncate\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtruncate\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    363\u001b[0m \u001b[43m      \u001b[49m\u001b[43moptions\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43moptions\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    364\u001b[0m \u001b[43m      \u001b[49m\u001b[43mkeep_alive\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mkeep_alive\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    365\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mmodel_dump\u001b[49m\u001b[43m(\u001b[49m\u001b[43mexclude_none\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[38;5;28;43;01mTrue\u001b[39;49;00m\u001b[43m)\u001b[49m\u001b[43m,\u001b[49m\n\u001b[1;32m    366\u001b[0m \u001b[43m  \u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/ollama/_client.py:175\u001b[0m, in \u001b[0;36mClient._request\u001b[0;34m(self, cls, stream, *args, **kwargs)\u001b[0m\n\u001b[1;32m    171\u001b[0m         \u001b[38;5;28;01myield\u001b[39;00m \u001b[38;5;28mcls\u001b[39m(\u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mpart)\n\u001b[1;32m    173\u001b[0m   \u001b[38;5;28;01mreturn\u001b[39;00m inner()\n\u001b[0;32m--> 175\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mcls\u001b[39m(\u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_request_raw\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\u001b[38;5;241m.\u001b[39mjson())\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/ollama/_client.py:116\u001b[0m, in \u001b[0;36mClient._request_raw\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m    115\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m_request_raw\u001b[39m(\u001b[38;5;28mself\u001b[39m, \u001b[38;5;241m*\u001b[39margs, \u001b[38;5;241m*\u001b[39m\u001b[38;5;241m*\u001b[39mkwargs):\n\u001b[0;32m--> 116\u001b[0m   r \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_client\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mrequest\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    117\u001b[0m   \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m    118\u001b[0m     r\u001b[38;5;241m.\u001b[39mraise_for_status()\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpx/_client.py:827\u001b[0m, in \u001b[0;36mrequest\u001b[0;34m(self, method, url, content, data, files, json, params, headers, cookies, auth, follow_redirects, timeout, extensions)\u001b[0m\n\u001b[1;32m    817\u001b[0m     message \u001b[38;5;241m=\u001b[39m (\n\u001b[1;32m    818\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mSetting per-request cookies=<...> is being deprecated, because \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    819\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mthe expected behaviour on cookie persistence is ambiguous. Set \u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    820\u001b[0m         \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mcookies directly on the client instance instead.\u001b[39m\u001b[38;5;124m\"\u001b[39m\n\u001b[1;32m    821\u001b[0m     )\n\u001b[1;32m    822\u001b[0m     warnings\u001b[38;5;241m.\u001b[39mwarn(message, \u001b[38;5;167;01mDeprecationWarning\u001b[39;00m)\n\u001b[1;32m    824\u001b[0m request \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mbuild_request(\n\u001b[1;32m    825\u001b[0m     method\u001b[38;5;241m=\u001b[39mmethod,\n\u001b[1;32m    826\u001b[0m     url\u001b[38;5;241m=\u001b[39murl,\n\u001b[0;32m--> 827\u001b[0m     content\u001b[38;5;241m=\u001b[39mcontent,\n\u001b[1;32m    828\u001b[0m     data\u001b[38;5;241m=\u001b[39mdata,\n\u001b[1;32m    829\u001b[0m     files\u001b[38;5;241m=\u001b[39mfiles,\n\u001b[1;32m    830\u001b[0m     json\u001b[38;5;241m=\u001b[39mjson,\n\u001b[1;32m    831\u001b[0m     params\u001b[38;5;241m=\u001b[39mparams,\n\u001b[1;32m    832\u001b[0m     headers\u001b[38;5;241m=\u001b[39mheaders,\n\u001b[1;32m    833\u001b[0m     cookies\u001b[38;5;241m=\u001b[39mcookies,\n\u001b[1;32m    834\u001b[0m     timeout\u001b[38;5;241m=\u001b[39mtimeout,\n\u001b[1;32m    835\u001b[0m     extensions\u001b[38;5;241m=\u001b[39mextensions,\n\u001b[1;32m    836\u001b[0m )\n\u001b[1;32m    837\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39msend(request, auth\u001b[38;5;241m=\u001b[39mauth, follow_redirects\u001b[38;5;241m=\u001b[39mfollow_redirects)\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpx/_client.py:916\u001b[0m, in \u001b[0;36msend\u001b[0;34m(self, request, stream, auth, follow_redirects)\u001b[0m\n\u001b[1;32m    913\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m \u001b[38;5;167;01mRuntimeError\u001b[39;00m(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mCannot send a request, as the client has been closed.\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m    915\u001b[0m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_state \u001b[38;5;241m=\u001b[39m ClientState\u001b[38;5;241m.\u001b[39mOPENED\n\u001b[0;32m--> 916\u001b[0m follow_redirects \u001b[38;5;241m=\u001b[39m (\n\u001b[1;32m    917\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mfollow_redirects\n\u001b[1;32m    918\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(follow_redirects, UseClientDefault)\n\u001b[1;32m    919\u001b[0m     \u001b[38;5;28;01melse\u001b[39;00m follow_redirects\n\u001b[1;32m    920\u001b[0m )\n\u001b[1;32m    922\u001b[0m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_set_timeout(request)\n\u001b[1;32m    924\u001b[0m auth \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_build_request_auth(request, auth)\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpx/_client.py:944\u001b[0m, in \u001b[0;36m_send_handling_auth\u001b[0;34m(self, request, auth, follow_redirects, history)\u001b[0m\n\u001b[1;32m    939\u001b[0m         response\u001b[38;5;241m.\u001b[39mclose()\n\u001b[1;32m    940\u001b[0m         \u001b[38;5;28;01mraise\u001b[39;00m exc\n\u001b[1;32m    942\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m_send_handling_auth\u001b[39m(\n\u001b[1;32m    943\u001b[0m     \u001b[38;5;28mself\u001b[39m,\n\u001b[0;32m--> 944\u001b[0m     request: Request,\n\u001b[1;32m    945\u001b[0m     auth: Auth,\n\u001b[1;32m    946\u001b[0m     follow_redirects: \u001b[38;5;28mbool\u001b[39m,\n\u001b[1;32m    947\u001b[0m     history: \u001b[38;5;28mlist\u001b[39m[Response],\n\u001b[1;32m    948\u001b[0m ) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m Response:\n\u001b[1;32m    949\u001b[0m     auth_flow \u001b[38;5;241m=\u001b[39m auth\u001b[38;5;241m.\u001b[39msync_auth_flow(request)\n\u001b[1;32m    950\u001b[0m     \u001b[38;5;28;01mtry\u001b[39;00m:\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpx/_client.py:981\u001b[0m, in \u001b[0;36m_send_handling_redirects\u001b[0;34m(self, request, follow_redirects, history)\u001b[0m\n\u001b[1;32m    973\u001b[0m     \u001b[38;5;28;01mfinally\u001b[39;00m:\n\u001b[1;32m    974\u001b[0m         auth_flow\u001b[38;5;241m.\u001b[39mclose()\n\u001b[1;32m    976\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m_send_handling_redirects\u001b[39m(\n\u001b[1;32m    977\u001b[0m     \u001b[38;5;28mself\u001b[39m,\n\u001b[1;32m    978\u001b[0m     request: Request,\n\u001b[1;32m    979\u001b[0m     follow_redirects: \u001b[38;5;28mbool\u001b[39m,\n\u001b[1;32m    980\u001b[0m     history: \u001b[38;5;28mlist\u001b[39m[Response],\n\u001b[0;32m--> 981\u001b[0m ) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m Response:\n\u001b[1;32m    982\u001b[0m     \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m:\n\u001b[1;32m    983\u001b[0m         \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28mlen\u001b[39m(history) \u001b[38;5;241m>\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39mmax_redirects:\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpx/_client.py:1016\u001b[0m, in \u001b[0;36m_send_single_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m   1013\u001b[0m \u001b[38;5;28;01mdef\u001b[39;00m \u001b[38;5;21m_send_single_request\u001b[39m(\u001b[38;5;28mself\u001b[39m, request: Request) \u001b[38;5;241m-\u001b[39m\u001b[38;5;241m>\u001b[39m Response:\n\u001b[1;32m   1014\u001b[0m \u001b[38;5;250m    \u001b[39m\u001b[38;5;124;03m\"\"\"\u001b[39;00m\n\u001b[1;32m   1015\u001b[0m \u001b[38;5;124;03m    Sends a single request, without handling any redirections.\u001b[39;00m\n\u001b[0;32m-> 1016\u001b[0m \u001b[38;5;124;03m    \"\"\"\u001b[39;00m\n\u001b[1;32m   1017\u001b[0m     transport \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_transport_for_url(request\u001b[38;5;241m.\u001b[39murl)\n\u001b[1;32m   1018\u001b[0m     timer \u001b[38;5;241m=\u001b[39m Timer()\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpx/_transports/default.py:250\u001b[0m, in \u001b[0;36mhandle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m      0\u001b[0m <Error retrieving source code with stack_data see ipython/ipython#13598>\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpcore/_sync/connection_pool.py:256\u001b[0m, in \u001b[0;36mConnectionPool.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    253\u001b[0m         closing \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_assign_requests_to_connections()\n\u001b[1;32m    255\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_close_connections(closing)\n\u001b[0;32m--> 256\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m exc \u001b[38;5;28;01mfrom\u001b[39;00m \u001b[38;5;28;01mNone\u001b[39;00m\n\u001b[1;32m    258\u001b[0m \u001b[38;5;66;03m# Return the response. Note that in this case we still have to manage\u001b[39;00m\n\u001b[1;32m    259\u001b[0m \u001b[38;5;66;03m# the point at which the response is closed.\u001b[39;00m\n\u001b[1;32m    260\u001b[0m \u001b[38;5;28;01massert\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(response\u001b[38;5;241m.\u001b[39mstream, typing\u001b[38;5;241m.\u001b[39mIterable)\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpcore/_sync/connection_pool.py:236\u001b[0m, in \u001b[0;36mConnectionPool.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    232\u001b[0m connection \u001b[38;5;241m=\u001b[39m pool_request\u001b[38;5;241m.\u001b[39mwait_for_connection(timeout\u001b[38;5;241m=\u001b[39mtimeout)\n\u001b[1;32m    234\u001b[0m \u001b[38;5;28;01mtry\u001b[39;00m:\n\u001b[1;32m    235\u001b[0m     \u001b[38;5;66;03m# Send the request on the assigned connection.\u001b[39;00m\n\u001b[0;32m--> 236\u001b[0m     response \u001b[38;5;241m=\u001b[39m \u001b[43mconnection\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mhandle_request\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    237\u001b[0m \u001b[43m        \u001b[49m\u001b[43mpool_request\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mrequest\u001b[49m\n\u001b[1;32m    238\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    239\u001b[0m \u001b[38;5;28;01mexcept\u001b[39;00m ConnectionNotAvailable:\n\u001b[1;32m    240\u001b[0m     \u001b[38;5;66;03m# In some cases a connection may initially be available to\u001b[39;00m\n\u001b[1;32m    241\u001b[0m     \u001b[38;5;66;03m# handle a request, but then become unavailable.\u001b[39;00m\n\u001b[1;32m    242\u001b[0m     \u001b[38;5;66;03m#\u001b[39;00m\n\u001b[1;32m    243\u001b[0m     \u001b[38;5;66;03m# In this case we clear the connection and try again.\u001b[39;00m\n\u001b[1;32m    244\u001b[0m     pool_request\u001b[38;5;241m.\u001b[39mclear_connection()\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpcore/_sync/connection.py:103\u001b[0m, in \u001b[0;36mHTTPConnection.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    100\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_connect_failed \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mTrue\u001b[39;00m\n\u001b[1;32m    101\u001b[0m     \u001b[38;5;28;01mraise\u001b[39;00m exc\n\u001b[0;32m--> 103\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_connection\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mhandle_request\u001b[49m\u001b[43m(\u001b[49m\u001b[43mrequest\u001b[49m\u001b[43m)\u001b[49m\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpcore/_sync/http11.py:136\u001b[0m, in \u001b[0;36mHTTP11Connection.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    134\u001b[0m     \u001b[38;5;28;01mwith\u001b[39;00m Trace(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mresponse_closed\u001b[39m\u001b[38;5;124m\"\u001b[39m, logger, request) \u001b[38;5;28;01mas\u001b[39;00m trace:\n\u001b[1;32m    135\u001b[0m         \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_response_closed()\n\u001b[0;32m--> 136\u001b[0m \u001b[38;5;28;01mraise\u001b[39;00m exc\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpcore/_sync/http11.py:106\u001b[0m, in \u001b[0;36mHTTP11Connection.handle_request\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m     95\u001b[0m     \u001b[38;5;28;01mpass\u001b[39;00m\n\u001b[1;32m     97\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m Trace(\n\u001b[1;32m     98\u001b[0m     \u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mreceive_response_headers\u001b[39m\u001b[38;5;124m\"\u001b[39m, logger, request, kwargs\n\u001b[1;32m     99\u001b[0m ) \u001b[38;5;28;01mas\u001b[39;00m trace:\n\u001b[1;32m    100\u001b[0m     (\n\u001b[1;32m    101\u001b[0m         http_version,\n\u001b[1;32m    102\u001b[0m         status,\n\u001b[1;32m    103\u001b[0m         reason_phrase,\n\u001b[1;32m    104\u001b[0m         headers,\n\u001b[1;32m    105\u001b[0m         trailing_data,\n\u001b[0;32m--> 106\u001b[0m     ) \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_receive_response_headers\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    107\u001b[0m     trace\u001b[38;5;241m.\u001b[39mreturn_value \u001b[38;5;241m=\u001b[39m (\n\u001b[1;32m    108\u001b[0m         http_version,\n\u001b[1;32m    109\u001b[0m         status,\n\u001b[1;32m    110\u001b[0m         reason_phrase,\n\u001b[1;32m    111\u001b[0m         headers,\n\u001b[1;32m    112\u001b[0m     )\n\u001b[1;32m    114\u001b[0m network_stream \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_network_stream\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpcore/_sync/http11.py:177\u001b[0m, in \u001b[0;36mHTTP11Connection._receive_response_headers\u001b[0;34m(self, request)\u001b[0m\n\u001b[1;32m    174\u001b[0m timeout \u001b[38;5;241m=\u001b[39m timeouts\u001b[38;5;241m.\u001b[39mget(\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mread\u001b[39m\u001b[38;5;124m\"\u001b[39m, \u001b[38;5;28;01mNone\u001b[39;00m)\n\u001b[1;32m    176\u001b[0m \u001b[38;5;28;01mwhile\u001b[39;00m \u001b[38;5;28;01mTrue\u001b[39;00m:\n\u001b[0;32m--> 177\u001b[0m     event \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_receive_event\u001b[49m\u001b[43m(\u001b[49m\u001b[43mtimeout\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtimeout\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    178\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m \u001b[38;5;28misinstance\u001b[39m(event, h11\u001b[38;5;241m.\u001b[39mResponse):\n\u001b[1;32m    179\u001b[0m         \u001b[38;5;28;01mbreak\u001b[39;00m\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpcore/_sync/http11.py:217\u001b[0m, in \u001b[0;36mHTTP11Connection._receive_event\u001b[0;34m(self, timeout)\u001b[0m\n\u001b[1;32m    214\u001b[0m     event \u001b[38;5;241m=\u001b[39m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_h11_state\u001b[38;5;241m.\u001b[39mnext_event()\n\u001b[1;32m    216\u001b[0m \u001b[38;5;28;01mif\u001b[39;00m event \u001b[38;5;129;01mis\u001b[39;00m h11\u001b[38;5;241m.\u001b[39mNEED_DATA:\n\u001b[0;32m--> 217\u001b[0m     data \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_network_stream\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mread\u001b[49m\u001b[43m(\u001b[49m\n\u001b[1;32m    218\u001b[0m \u001b[43m        \u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mREAD_NUM_BYTES\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43mtimeout\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mtimeout\u001b[49m\n\u001b[1;32m    219\u001b[0m \u001b[43m    \u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m    221\u001b[0m     \u001b[38;5;66;03m# If we feed this case through h11 we'll raise an exception like:\u001b[39;00m\n\u001b[1;32m    222\u001b[0m     \u001b[38;5;66;03m#\u001b[39;00m\n\u001b[1;32m    223\u001b[0m     \u001b[38;5;66;03m#     httpcore.RemoteProtocolError: can't handle event type\u001b[39;00m\n\u001b[0;32m   (...)\u001b[0m\n\u001b[1;32m    227\u001b[0m     \u001b[38;5;66;03m# perspective. Instead we handle this case distinctly and treat\u001b[39;00m\n\u001b[1;32m    228\u001b[0m     \u001b[38;5;66;03m# it as a ConnectError.\u001b[39;00m\n\u001b[1;32m    229\u001b[0m     \u001b[38;5;28;01mif\u001b[39;00m data \u001b[38;5;241m==\u001b[39m \u001b[38;5;124mb\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124m\"\u001b[39m \u001b[38;5;129;01mand\u001b[39;00m \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_h11_state\u001b[38;5;241m.\u001b[39mtheir_state \u001b[38;5;241m==\u001b[39m h11\u001b[38;5;241m.\u001b[39mSEND_RESPONSE:\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/httpcore/_backends/sync.py:128\u001b[0m, in \u001b[0;36mSyncStream.read\u001b[0;34m(self, max_bytes, timeout)\u001b[0m\n\u001b[1;32m    126\u001b[0m \u001b[38;5;28;01mwith\u001b[39;00m map_exceptions(exc_map):\n\u001b[1;32m    127\u001b[0m     \u001b[38;5;28mself\u001b[39m\u001b[38;5;241m.\u001b[39m_sock\u001b[38;5;241m.\u001b[39msettimeout(timeout)\n\u001b[0;32m--> 128\u001b[0m     \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[38;5;28;43mself\u001b[39;49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43m_sock\u001b[49m\u001b[38;5;241;43m.\u001b[39;49m\u001b[43mrecv\u001b[49m\u001b[43m(\u001b[49m\u001b[43mmax_bytes\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[0;31mKeyboardInterrupt\u001b[0m: "
     ]
    }
   ],
   "source": [
    "embd = OllamaEmbeddings(model=\"nomic-embed-text\")  # You can specify a model like llama-2-7b-chat\n",
    "\n",
    "# Add to Chroma vectorstore\n",
    "vectorstore = Chroma.from_documents(\n",
    "    documents=doc_splits,\n",
    "    collection_name=\"rag-chroma\",\n",
    "    embedding=embd,\n",
    "    persist_directory=\"./db2\"\n",
    ")\n",
    "\n",
    "# Create retriever for question-answering tasks\n",
    "retriever = vectorstore.as_retriever()\n",
    "\n",
    "# Example usage of retriever\n",
    "query = \"What are the uses of Amoxicillin?\"\n",
    "results = retriever.get_relevant_documents(query)\n",
    "print(\"\\n--- Relevant Documents ---\\n\")\n",
    "for result in results:\n",
    "    print(f\"Content:\\n{result.page_content}\")\n",
    "    print(f\"Metadata: {result.metadata}\")\n",
    "    print(\"---\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Processing batch 1\n",
      "bleh\n"
     ]
    },
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "/var/folders/9b/zk85r2w17rnb_wswllkymxm80000gp/T/ipykernel_87858/2720776962.py:70: LangChainDeprecationWarning: Since Chroma 0.4.x the manual persistence method is no longer supported as docs are automatically persisted.\n",
      "  vectorstore.persist()\n"
     ]
    },
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Batch 1 persisted successfully.\n",
      "Processing batch 2\n",
      "Batch 2 persisted successfully.\n",
      "Processing batch 3\n",
      "Batch 3 persisted successfully.\n",
      "Processing batch 4\n",
      "Batch 4 persisted successfully.\n",
      "Processing batch 5\n",
      "Batch 5 persisted successfully.\n",
      "Processing batch 6\n",
      "Batch 6 persisted successfully.\n",
      "Processing batch 7\n",
      "Batch 7 persisted successfully.\n",
      "Processing batch 8\n",
      "Batch 8 persisted successfully.\n",
      "Processing batch 9\n",
      "Batch 9 persisted successfully.\n",
      "Processing batch 10\n",
      "Batch 10 persisted successfully.\n",
      "Processing batch 11\n",
      "Batch 11 persisted successfully.\n",
      "Processing batch 12\n",
      "Batch 12 persisted successfully.\n",
      "Processing batch 13\n",
      "Batch 13 persisted successfully.\n",
      "Processing batch 14\n",
      "Batch 14 persisted successfully.\n",
      "Processing batch 15\n",
      "Batch 15 persisted successfully.\n",
      "Processing batch 16\n",
      "Batch 16 persisted successfully.\n",
      "Processing batch 17\n",
      "Batch 17 persisted successfully.\n",
      "Processing batch 18\n",
      "Batch 18 persisted successfully.\n",
      "Processing batch 19\n",
      "Batch 19 persisted successfully.\n",
      "Processing batch 20\n",
      "Batch 20 persisted successfully.\n",
      "Processing batch 21\n",
      "Batch 21 persisted successfully.\n",
      "Processing batch 22\n",
      "Batch 22 persisted successfully.\n",
      "Processing batch 23\n",
      "Batch 23 persisted successfully.\n",
      "Processing batch 24\n",
      "Batch 24 persisted successfully.\n",
      "Processing batch 25\n",
      "Batch 25 persisted successfully.\n",
      "Processing batch 26\n",
      "Batch 26 persisted successfully.\n",
      "Processing batch 27\n",
      "Batch 27 persisted successfully.\n",
      "Processing batch 28\n",
      "Batch 28 persisted successfully.\n",
      "Processing batch 29\n",
      "Batch 29 persisted successfully.\n",
      "Processing batch 30\n",
      "Batch 30 persisted successfully.\n",
      "Processing batch 31\n",
      "Batch 31 persisted successfully.\n",
      "Processing batch 32\n",
      "Batch 32 persisted successfully.\n",
      "Processing batch 33\n",
      "Batch 33 persisted successfully.\n",
      "Processing batch 34\n",
      "Batch 34 persisted successfully.\n",
      "Processing batch 35\n",
      "Batch 35 persisted successfully.\n",
      "Processing batch 36\n",
      "Batch 36 persisted successfully.\n",
      "Processing batch 37\n",
      "Batch 37 persisted successfully.\n",
      "Processing batch 38\n",
      "Batch 38 persisted successfully.\n",
      "Processing batch 39\n",
      "Batch 39 persisted successfully.\n",
      "Processing batch 40\n",
      "Batch 40 persisted successfully.\n",
      "Processing batch 41\n",
      "Batch 41 persisted successfully.\n",
      "Processing batch 42\n",
      "Batch 42 persisted successfully.\n",
      "Processing batch 43\n",
      "Batch 43 persisted successfully.\n",
      "Processing batch 44\n",
      "Batch 44 persisted successfully.\n",
      "Processing batch 45\n",
      "Batch 45 persisted successfully.\n",
      "Processing batch 46\n",
      "Batch 46 persisted successfully.\n",
      "Processing batch 47\n",
      "Batch 47 persisted successfully.\n",
      "Processing batch 48\n",
      "Batch 48 persisted successfully.\n",
      "Processing batch 49\n",
      "Batch 49 persisted successfully.\n",
      "Processing batch 50\n",
      "Batch 50 persisted successfully.\n",
      "Processing batch 51\n",
      "Batch 51 persisted successfully.\n",
      "Processing batch 52\n",
      "Batch 52 persisted successfully.\n",
      "Processing batch 53\n",
      "Batch 53 persisted successfully.\n",
      "Processing batch 54\n",
      "Batch 54 persisted successfully.\n",
      "Processing batch 55\n",
      "Batch 55 persisted successfully.\n",
      "Processing batch 56\n",
      "Batch 56 persisted successfully.\n",
      "Processing batch 57\n",
      "Batch 57 persisted successfully.\n",
      "Processing batch 58\n",
      "Batch 58 persisted successfully.\n",
      "Processing batch 59\n",
      "Batch 59 persisted successfully.\n",
      "Processing batch 60\n",
      "Batch 60 persisted successfully.\n",
      "Processing batch 61\n",
      "Batch 61 persisted successfully.\n",
      "Processing batch 62\n",
      "Batch 62 persisted successfully.\n",
      "Processing batch 63\n",
      "Batch 63 persisted successfully.\n",
      "Processing batch 64\n",
      "Batch 64 persisted successfully.\n",
      "Processing batch 65\n",
      "Batch 65 persisted successfully.\n",
      "Processing batch 66\n",
      "Batch 66 persisted successfully.\n",
      "Processing batch 67\n",
      "Batch 67 persisted successfully.\n",
      "Processing batch 68\n",
      "Batch 68 persisted successfully.\n",
      "Processing batch 69\n",
      "Batch 69 persisted successfully.\n",
      "Processing batch 70\n",
      "Batch 70 persisted successfully.\n",
      "Processing batch 71\n",
      "Batch 71 persisted successfully.\n",
      "Processing batch 72\n",
      "Batch 72 persisted successfully.\n",
      "Processing batch 73\n",
      "Batch 73 persisted successfully.\n",
      "Processing batch 74\n",
      "Batch 74 persisted successfully.\n",
      "Processing batch 75\n",
      "Batch 75 persisted successfully.\n",
      "Processing batch 76\n",
      "Batch 76 persisted successfully.\n",
      "Processing batch 77\n",
      "Batch 77 persisted successfully.\n",
      "Processing batch 78\n",
      "Batch 78 persisted successfully.\n",
      "Processing batch 79\n",
      "Batch 79 persisted successfully.\n",
      "Processing batch 80\n",
      "Batch 80 persisted successfully.\n",
      "Processing batch 81\n",
      "Batch 81 persisted successfully.\n",
      "Processing batch 82\n",
      "Batch 82 persisted successfully.\n",
      "Processing batch 83\n",
      "Batch 83 persisted successfully.\n",
      "Processing batch 84\n",
      "Batch 84 persisted successfully.\n",
      "Processing batch 85\n",
      "Batch 85 persisted successfully.\n",
      "Processing batch 86\n",
      "Batch 86 persisted successfully.\n",
      "Processing batch 87\n",
      "Batch 87 persisted successfully.\n",
      "Processing batch 88\n",
      "Batch 88 persisted successfully.\n",
      "Processing batch 89\n",
      "Batch 89 persisted successfully.\n",
      "Processing batch 90\n",
      "Batch 90 persisted successfully.\n",
      "Processing batch 91\n",
      "Batch 91 persisted successfully.\n",
      "Processing batch 92\n",
      "Batch 92 persisted successfully.\n",
      "Processing batch 93\n",
      "Batch 93 persisted successfully.\n",
      "Processing batch 94\n",
      "Batch 94 persisted successfully.\n",
      "Processing batch 95\n",
      "Batch 95 persisted successfully.\n",
      "Processing batch 96\n",
      "Batch 96 persisted successfully.\n",
      "Processing batch 97\n",
      "Batch 97 persisted successfully.\n"
     ]
    },
    {
     "ename": "TypeError",
     "evalue": "Chroma.__init__() got an unexpected keyword argument 'embedding'",
     "output_type": "error",
     "traceback": [
      "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
      "Cell \u001b[0;32mIn[24], line 74\u001b[0m\n\u001b[1;32m     71\u001b[0m     \u001b[38;5;28mprint\u001b[39m(\u001b[38;5;124mf\u001b[39m\u001b[38;5;124m\"\u001b[39m\u001b[38;5;124mBatch \u001b[39m\u001b[38;5;132;01m{\u001b[39;00mbatch_num\u001b[38;5;250m \u001b[39m\u001b[38;5;241m+\u001b[39m\u001b[38;5;250m \u001b[39m\u001b[38;5;241m1\u001b[39m\u001b[38;5;132;01m}\u001b[39;00m\u001b[38;5;124m persisted successfully.\u001b[39m\u001b[38;5;124m\"\u001b[39m)\n\u001b[1;32m     73\u001b[0m \u001b[38;5;66;03m# Create retriever for question-answering tasks\u001b[39;00m\n\u001b[0;32m---> 74\u001b[0m vectorstore \u001b[38;5;241m=\u001b[39m \u001b[43mChroma\u001b[49m\u001b[43m(\u001b[49m\u001b[43mpersist_directory\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43mPERSIST_DIR\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[43membedding\u001b[49m\u001b[38;5;241;43m=\u001b[39;49m\u001b[43membd\u001b[49m\u001b[43m)\u001b[49m\n\u001b[1;32m     75\u001b[0m retriever \u001b[38;5;241m=\u001b[39m vectorstore\u001b[38;5;241m.\u001b[39mas_retriever()\n\u001b[1;32m     77\u001b[0m \u001b[38;5;66;03m# Example usage of retriever\u001b[39;00m\n",
      "File \u001b[0;32m/opt/anaconda3/envs/llm_hackathon/lib/python3.12/site-packages/langchain_core/_api/deprecation.py:216\u001b[0m, in \u001b[0;36mdeprecated.<locals>.deprecate.<locals>.finalize.<locals>.warn_if_direct_instance\u001b[0;34m(self, *args, **kwargs)\u001b[0m\n\u001b[1;32m    214\u001b[0m     warned \u001b[38;5;241m=\u001b[39m \u001b[38;5;28;01mTrue\u001b[39;00m\n\u001b[1;32m    215\u001b[0m     emit_warning()\n\u001b[0;32m--> 216\u001b[0m \u001b[38;5;28;01mreturn\u001b[39;00m \u001b[43mwrapped\u001b[49m\u001b[43m(\u001b[49m\u001b[38;5;28;43mself\u001b[39;49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43margs\u001b[49m\u001b[43m,\u001b[49m\u001b[43m \u001b[49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[38;5;241;43m*\u001b[39;49m\u001b[43mkwargs\u001b[49m\u001b[43m)\u001b[49m\n",
      "\u001b[0;31mTypeError\u001b[0m: Chroma.__init__() got an unexpected keyword argument 'embedding'"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import json\n",
    "from langchain.schema import Document\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from langchain_community.vectorstores import Chroma\n",
    "from langchain_ollama import OllamaEmbeddings\n",
    "\n",
    "# Directory containing JSON files\n",
    "DATA_DIR = \"./datasets/microlabs_usa\"\n",
    "PERSIST_DIR = \"./db4\"  # Persistent store for ChromaDB\n",
    "\n",
    "# Batch size for processing documents\n",
    "BATCH_SIZE = 50\n",
    "TOP_N = 10\n",
    "\n",
    "# Read JSON files and convert to LangChain documents\n",
    "def load_top_n_json_to_documents(data_dir, top_n):\n",
    "    docs = []\n",
    "    # Get all JSON files and sort them alphabetically\n",
    "    json_files = sorted([f for f in os.listdir(data_dir) if f.endswith(\".json\")])[:top_n]\n",
    "    \n",
    "    for file_name in json_files:\n",
    "        file_path = os.path.join(data_dir, file_name)\n",
    "        with open(file_path, \"r\") as f:\n",
    "            json_data = json.load(f)\n",
    "            drug_name = file_name.replace(\".json\", \"\")  # Extract drug name from filename\n",
    "            \n",
    "            # Iterate over the keys in the JSON\n",
    "            for key, value in json_data.items():\n",
    "                # Combine drug name, key name, and content\n",
    "                chunk_content = f\"Drug Name: {drug_name}\\nKey: {key}\\nContent:\\n{value}\"\n",
    "                metadata = {\"source\": file_name, \"drug_name\": drug_name, \"key\": key}\n",
    "                docs.append(Document(page_content=chunk_content, metadata=metadata))\n",
    "    return docs\n",
    "\n",
    "# Load top N JSON files as documents\n",
    "docs_list = load_top_n_json_to_documents(DATA_DIR, TOP_N)\n",
    "\n",
    "\n",
    "# Initialize the text splitter\n",
    "text_splitter = RecursiveCharacterTextSplitter.from_tiktoken_encoder(\n",
    "    chunk_size=800, chunk_overlap=150\n",
    ")\n",
    "\n",
    "# Split documents into smaller chunks\n",
    "all_chunks = text_splitter.split_documents(docs_list)\n",
    "\n",
    "# Batch processing: split all chunks into batches of BATCH_SIZE\n",
    "def chunk_batches(chunks, batch_size):\n",
    "    for i in range(0, len(chunks), batch_size):\n",
    "        yield chunks[i:i + batch_size]\n",
    "\n",
    "# Initialize Ollama embeddings\n",
    "embd = OllamaEmbeddings(model=\"nomic-embed-text\")  # Specify the embedding model\n",
    "\n",
    "# Process each batch of 100 documents\n",
    "\n",
    "for batch_num, batch in enumerate(chunk_batches(all_chunks, BATCH_SIZE)):\n",
    "    print(f\"Processing batch {batch_num + 1}\")\n",
    "    if os.path.exists(PERSIST_DIR):\n",
    "        # Load existing database\n",
    "        vectorstore = Chroma(persist_directory=PERSIST_DIR, embedding_function=embd)\n",
    "    else:\n",
    "        # Create a new database for the first batch'ArithmeticError\n",
    "        print('bleh')\n",
    "        vectorstore = Chroma(persist_directory=PERSIST_DIR, embedding_function=embd)\n",
    "\n",
    "    # Add batch to the vectorstore\n",
    "    vectorstore.add_documents(batch)\n",
    "    vectorstore.persist()\n",
    "    print(f\"Batch {batch_num + 1} persisted successfully.\")\n",
    "\n",
    "# Create retriever for question-answering tasks\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 166,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "--- Relevant Documents ---\n",
      "\n",
      "Content:\n",
      "Drug Name: Amoxicillin and Clavulanate Potassium for Oral Suspension, USP\n",
      "Key: 1 INDICATIONS AND USAGE\n",
      "Content:\n",
      "Amoxicillin and clavulanate potassium for oral suspension is indicated for the treatment of infections in adults and pediatric patients, due to susceptible isolates of the designated bacteria in the conditions listed below:Lower Respiratory Tract Infections- caused by beta‑lactamase‑producing isolates ofHaemophilus influenzaeandMoraxella catarrhalis.Acute Bacterial Otitis Media- caused by beta‑lactamase‑producing isolates ofH. influenzaeandM. catarrhalis.Sinusitis- caused by beta‑lactamase‑producing isolates ofH. influenzaeandM. catarrhalis.Skin and Skin Structure Infections- caused by beta‑lactamase‑producing isolates ofStaphylococcus aureus,Escherichia coli,andKlebsiellaspecies.Urinary Tract Infections- caused by beta‑lactamase‑producing isolates ofE. coli,Klebsiellaspecies, andEnterobacterspecies.Limitations of UseWhen susceptibility test results show susceptibility to amoxicillin, indicating no beta-lactamase production, amoxicillin and clavulanate potassium  for oral suspension should not be used.UsageTo reduce the development of drug‑resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium for oral suspension and other antibacterial drugs, amoxicillin and clavulanate potassium for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.\n",
      "---\n",
      "Content:\n",
      "Amoxicillin and clavulanate potassium for oral suspension is indicated for the treatment of infections in adults and pediatric patients, due to susceptible isolates of the designated bacteria in the conditions listed below:Lower Respiratory Tract Infections- caused by beta‑lactamase‑producing isolates ofHaemophilus influenzaeandMoraxella catarrhalis.Acute Bacterial Otitis Media- caused by beta‑lactamase‑producing isolates ofH. influenzaeandM. catarrhalis.Sinusitis- caused by beta‑lactamase‑producing isolates ofH. influenzaeandM. catarrhalis.Skin and Skin Structure Infections- caused by beta‑lactamase‑producing isolates ofStaphylococcus aureus,Escherichia coli,andKlebsiellaspecies.Urinary Tract Infections- caused by beta‑lactamase‑producing isolates ofE. coli,Klebsiellaspecies, andEnterobacterspecies.Limitations of UseWhen susceptibility test results show susceptibility to amoxicillin, indicating no beta-lactamase production, amoxicillin and clavulanate potassium  for oral suspension should not be used.UsageTo reduce the development of drug‑resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium for oral suspension and other antibacterial drugs, amoxicillin and clavulanate potassium for oral suspension should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.\n",
      "---\n",
      "Content:\n",
      "Amoxicillin and clavulanate potassium tablets are indicated for the treatment of infections in adults and pediatric patients, due to susceptible isolates of the designated bacteria in the conditions listed below:•Lower Respiratory Tract Infections- caused by beta‑lactamase‑producing isolates ofHaemophilus influenzaeandMoraxella catarrhalis.•Acute Bacterial Otitis Media- caused by beta‑lactamase‑producing isolates ofH. influenzaeandM. catarrhalis.•Sinusitis- caused by beta‑lactamase‑producing isolates ofH. influenzaeandM. catarrhalis.•Skin and Skin Structure Infections- caused by beta‑lactamase‑producing isolates ofStaphylococcus aureus, Escherichia coli,andKlebsiellaspecies.•Urinary Tract Infections- caused by beta‑lactamase‑producing isolates ofE. coli, Klebsiellaspecies,andEnterobacterspecies.Limitations of UseWhen susceptibility test results show susceptibility to amoxicillin, indicating no beta-lactamase production, amoxicillin and clavulanate potassium tablets should not be used.UsageTo reduce the development of drug‑resistant bacteria and maintain the effectiveness of amoxicillin and clavulanate potassium tablets and other antibacterial drugs, amoxicillin and clavulanate potassium tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.\n",
      "---\n",
      "Content:\n",
      "Drug Name: Amoxicillin and Clavulanate Potassium for Oral Suspension, USP\n",
      "Key: 2 DOSAGE AND ADMINISTRATION\n",
      "Content:\n",
      "---\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "import json\n",
    "from langchain.schema import Document\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "from langchain_community.vectorstores import Chroma\n",
    "from langchain_ollama import OllamaEmbeddings\n",
    "PERSIST_DIR = \"./db4\"\n",
    "embd = OllamaEmbeddings(model=\"nomic-embed-text\") \n",
    "vectorstore = Chroma(persist_directory=PERSIST_DIR, embedding_function=embd)\n",
    "retriever = vectorstore.as_retriever()\n",
    "\n",
    "# Example usage of retriever\n",
    "query = \"What are the uses of Amoxicillin?\"\n",
    "results = retriever.get_relevant_documents(query)\n",
    "print(\"\\n--- Relevant Documents ---\\n\")\n",
    "for result in results:\n",
    "    print(f\"Content:\\n{result.page_content}\")\n",
    "    # print(f\"Metadata: {result.metadata}\")\n",
    "    print(\"---\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 167,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain.tools.retriever import create_retriever_tool\n",
    "\n",
    "retriever_tool = create_retriever_tool(\n",
    "    retriever,\n",
    "    \"drugs\",\n",
    "    \"Search and return information about drugs\",\n",
    ")\n",
    "\n",
    "tools = [retriever_tool]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langgraph.graph import MessagesState\n",
    "# The agent state is the input to each node in the graph\n",
    "class AgentState(MessagesState):\n",
    "    # The 'next' field indicates where to route to next\n",
    "    next: str"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Load environment variables\n",
    "import os\n",
    "from dotenv import load_dotenv\n",
    "from langchain_groq import ChatGroq\n",
    "\n",
    "load_dotenv(\"./secrets/secrets.env\")\n",
    "groq_api_key = os.getenv('GROQ_API_KEY')\n",
    "llm = ChatGroq(groq_api_key=groq_api_key, model_name=\"llama-3.1-3b-preview\")\n",
    "\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 57,
   "metadata": {},
   "outputs": [],
   "source": [
    "from langchain_ollama import ChatOllama\n",
    "llm2 = ChatOllama(model=\"llama3.1\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 58,
   "metadata": {},
   "outputs": [],
   "source": [
    "from ollama_functions import OllamaFunctions\n",
    "llm = OllamaFunctions(model=\"llama3.1\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 156,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "True"
      ]
     },
     "execution_count": 156,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from dotenv import load_dotenv\n",
    "load_dotenv(override=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 168,
   "metadata": {},
   "outputs": [],
   "source": [
    "from typing import Literal\n",
    "from typing_extensions import TypedDict\n",
    "\n",
    "\n",
    "members = [\"doctor\", \"description\",\"warning\"]\n",
    "# Our team supervisor is an LLM node. It just picks the next agent to process\n",
    "# and decides when the work is completed\n",
    "options = members + [\"FINISH\"]\n",
    "\n",
    "system_prompt = (\n",
    "    \"You are a supervisor tasked with managing a conversation between the\"\n",
    "    f\" following workers: {members}. Given the following user request,\"\n",
    "    \" respond with the worker to act next. Each worker will perform a\"\n",
    "    \" task and respond with their results and status. When finished,\"\n",
    "    \" respond with FINISH.\"\n",
    ")\n",
    "\n",
    "\n",
    "from pydantic import BaseModel, Field\n",
    "from typing import Literal\n",
    "\n",
    "class Router(BaseModel):\n",
    "    \"\"\"Worker to route to next. If no workers are needed, route to FINISH.\"\"\"\n",
    "\n",
    "    next: Literal[\"doctor\", \"description\", \"warning\", \"FINISH\"] = Field(\n",
    "        ...,\n",
    "        description=\"The name of the next worker. Use 'FINISH' if no workers are needed.\",\n",
    "    )\n",
    "\n",
    "\n",
    "def supervisor_node(state: AgentState) -> AgentState:\n",
    "    try:\n",
    "        messages = [\n",
    "        {\"role\": \"system\", \"content\": system_prompt},\n",
    "    ] + state[\"messages\"]\n",
    "        response = llm.with_structured_output(Router).invoke(messages)\n",
    "        print(response)\n",
    "        next_ = response.next\n",
    "        if next_ == \"FINISH\":\n",
    "            next_ = END\n",
    "\n",
    "        return {\"next\": next_}\n",
    "    except:\n",
    "        return {\"next\":END}\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 169,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<langgraph.graph.state.StateGraph at 0x13cfb5be0>"
      ]
     },
     "execution_count": 169,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "from langchain_core.messages import HumanMessage\n",
    "from langgraph.graph import StateGraph, START, END\n",
    "from langgraph.prebuilt import create_react_agent\n",
    "\n",
    "\n",
    "description_agent = create_react_agent(\n",
    "    llm, tools=[retriever_tool], state_modifier=\"You are a drug specialist which can give descriptions of a particular drug\")\n",
    "\n",
    "\n",
    "def description_node(state: AgentState) -> AgentState:\n",
    "    result = description_agent.invoke(state)\n",
    "    return {\n",
    "        \"messages\": [\n",
    "            HumanMessage(content=result[\"messages\"][-1].content, name=\"descriptor\")\n",
    "        ]\n",
    "    }\n",
    "\n",
    "\n",
    "# NOTE: THIS PERFORMS ARBITRARY CODE EXECUTION, WHICH CAN BE UNSAFE WHEN NOT SANDBOXED\n",
    "doctor_agent = create_react_agent(llm, tools=[retriever_tool],state_modifier=\"You are a doctor who has a knowledge base of all the drugs hwo to use it and for what disease to use it for\")\n",
    "\n",
    "\n",
    "def doctor_node(state: AgentState) -> AgentState:\n",
    "    result = doctor_agent.invoke(state)\n",
    "    return {\n",
    "        \"messages\": [HumanMessage(content=result[\"messages\"][-1].content, name=\"doctor\")]\n",
    "    }\n",
    "warning_agent =  create_react_agent(llm, tools=[retriever_tool],state_modifier = \"You are a warnnign agent who know what types of side effects each drug has along with dos and donts of drug\")\n",
    "\n",
    "def warning_node(state: AgentState) -> AgentState:\n",
    "    result = warning_agent.invoke(state)\n",
    "    return {\n",
    "        \"messages\": [HumanMessage(content=result[\"messages\"][-1].content, name=\"warning\")]\n",
    "    }\n",
    "\n",
    "\n",
    "builder = StateGraph(AgentState)\n",
    "builder.add_edge(START, \"supervisor\")\n",
    "builder.add_node(\"supervisor\", supervisor_node)\n",
    "builder.add_node(\"description\", description_agent)\n",
    "builder.add_node(\"doctor\", doctor_agent)\n",
    "builder.add_node(\"warning\", warning_agent)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 170,
   "metadata": {},
   "outputs": [],
   "source": [
    "for member in members:\n",
    "    # We want our workers to ALWAYS \"report back\" to the supervisor when done\n",
    "    builder.add_edge(member, \"supervisor\")\n",
    "\n",
    "# The supervisor populates the \"next\" field in the graph state\n",
    "# which routes to a node or finishes\n",
    "builder.add_conditional_edges(\"supervisor\", lambda state: state[\"next\"])\n",
    "# Finally, add entrypoint\n",
    "builder.add_edge(START, \"supervisor\")\n",
    "\n",
    "graph = builder.compile()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 171,
   "metadata": {},
   "outputs": [],
   "source": [
    "from IPython.display import display, Image"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 172,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<IPython.core.display.Image object>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "display(Image(graph.get_graph().draw_mermaid_png()))"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 174,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "next='doctor'\n",
      "((), {'supervisor': {'next': 'doctor'}})\n",
      "(('doctor:a97bcf62-29c1-17a9-c8d8-9a80a49c4857',), {'agent': {'messages': [AIMessage(content=[{'text': 'Let me search for information about Cromolyn Sodium and asthma treatment options to provide you with a comprehensive answer.', 'type': 'text'}, {'id': 'toolu_01HECLcgmhNBnJtkymMNnCdf', 'input': {'query': 'Cromolyn Sodium asthma treatment failure next step'}, 'name': 'drugs', 'type': 'tool_use'}], additional_kwargs={}, response_metadata={'id': 'msg_01Ravwq6Pe6ekyWwngq4ERym', 'model': 'claude-3-5-sonnet-20241022', 'stop_reason': 'tool_use', 'stop_sequence': None, 'usage': {'input_tokens': 445, 'output_tokens': 90}}, id='run-dc60300c-872b-496b-9717-b90456055af4-0', tool_calls=[{'name': 'drugs', 'args': {'query': 'Cromolyn Sodium asthma treatment failure next step'}, 'id': 'toolu_01HECLcgmhNBnJtkymMNnCdf', 'type': 'tool_call'}], usage_metadata={'input_tokens': 445, 'output_tokens': 90, 'total_tokens': 535, 'input_token_details': {}})]}})\n",
      "(('doctor:a97bcf62-29c1-17a9-c8d8-9a80a49c4857',), {'tools': {'messages': [ToolMessage(content='respiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022', name='drugs', id='632730f0-5034-40da-93ff-19dc2bdf3a99', tool_call_id='toolu_01HECLcgmhNBnJtkymMNnCdf')]}})\n",
      "(('doctor:a97bcf62-29c1-17a9-c8d8-9a80a49c4857',), {'agent': {'messages': [AIMessage(content=[{'text': 'Let me search for additional information about asthma treatment steps.', 'type': 'text'}, {'id': 'toolu_018QdcTpfrfMrbjSeDENfyAp', 'input': {'query': 'inhaled corticosteroids asthma treatment'}, 'name': 'drugs', 'type': 'tool_use'}], additional_kwargs={}, response_metadata={'id': 'msg_01VKhZm4ua3XiuTecRSoExiM', 'model': 'claude-3-5-sonnet-20241022', 'stop_reason': 'tool_use', 'stop_sequence': None, 'usage': {'input_tokens': 2509, 'output_tokens': 75}}, id='run-155559f3-289c-4b80-bc5b-19e749c2faf8-0', tool_calls=[{'name': 'drugs', 'args': {'query': 'inhaled corticosteroids asthma treatment'}, 'id': 'toolu_018QdcTpfrfMrbjSeDENfyAp', 'type': 'tool_call'}], usage_metadata={'input_tokens': 2509, 'output_tokens': 75, 'total_tokens': 2584, 'input_token_details': {}})]}})\n",
      "(('doctor:a97bcf62-29c1-17a9-c8d8-9a80a49c4857',), {'tools': {'messages': [ToolMessage(content='Anaphylactic ReactionsCelecoxib has been associated with anaphylactic reactions in patients with and without known hypersensitivity to celecoxib and in patients with aspirin sensitive asthma. Celecoxib is a sulfonamide and both NSAIDs and sulfonamides may cause allergic type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people [seeContraindications (4)andWarnings and Precautions (5.8)].Seek emergency help if any anaphylactic reaction occurs.5.8 Exacerbation of Asthma Related to Aspirin SensitivityA subpopulation of patients with asthma may have aspirin-sensitive asthma which may include chronic rhinosinusitis complicated by nasal polyps; severe, potentially fatal bronchospasm; and/or intolerance to aspirin and other NSAIDs. Because cross-reactivity between aspirin and other NSAIDs has been reported in such aspirin-sensitive patients, celecoxib is contraindicated in patients with this form of aspirin sensitivity [seeContraindications (4)]. When celecoxib is used in patients with preexisting asthma (without known aspirin sensitivity), monitor patients for changes in the signs and symptoms of asthma.5.9 Serious Skin ReactionsSerious skin reactions have occurred following treatment with celecoxib, including erythema multiforme, exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalizedexanthematous pustulosis (AGEP). These serious events may occur without warning and can be fatal.Inform patients about the signs and symptoms of serious skin reactions, and to discontinue the use of celecoxib at the first appearance of skin rash or any other sign of hypersensitivity. Celecoxib is contraindicated in patients with previous serious skin reactions to NSAIDs [seeContraindications (4)].5.10 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Drug\\n\\nAnaphylactic ReactionsCelecoxib has been associated with anaphylactic reactions in patients with and without known hypersensitivity to celecoxib and in patients with aspirin sensitive asthma. Celecoxib is a sulfonamide and both NSAIDs and sulfonamides may cause allergic type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people [seeContraindications (4)andWarnings and Precautions (5.8)].Seek emergency help if any anaphylactic reaction occurs.5.8 Exacerbation of Asthma Related to Aspirin SensitivityA subpopulation of patients with asthma may have aspirin-sensitive asthma which may include chronic rhinosinusitis complicated by nasal polyps; severe, potentially fatal bronchospasm; and/or intolerance to aspirin and other NSAIDs. Because cross-reactivity between aspirin and other NSAIDs has been reported in such aspirin-sensitive patients, celecoxib is contraindicated in patients with this form of aspirin sensitivity [seeContraindications (4)]. When celecoxib is used in patients with preexisting asthma (without known aspirin sensitivity), monitor patients for changes in the signs and symptoms of asthma.5.9 Serious Skin ReactionsSerious skin reactions have occurred following treatment with celecoxib, including erythema multiforme, exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalizedexanthematous pustulosis (AGEP). These serious events may occur without warning and can be fatal.Inform patients about the signs and symptoms of serious skin reactions, and to discontinue the use of celecoxib at the first appearance of skin rash or any other sign of hypersensitivity. Celecoxib is contraindicated in patients with previous serious skin reactions to NSAIDs [seeContraindications (4)].5.10 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Drug\\n\\nAnaphylactic ReactionsCelecoxib has been associated with anaphylactic reactions in patients with and without known hypersensitivity to celecoxib and in patients with aspirin sensitive asthma. Celecoxib is a sulfonamide and both NSAIDs and sulfonamides may cause allergic type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people [seeContraindications (4)andWarnings and Precautions (5.8)].Seek emergency help if any anaphylactic reaction occurs.5.8 Exacerbation of Asthma Related to Aspirin SensitivityA subpopulation of patients with asthma may have aspirin-sensitive asthma which may include chronic rhinosinusitis complicated by nasal polyps; severe, potentially fatal bronchospasm; and/or intolerance to aspirin and other NSAIDs. Because cross-reactivity between aspirin and other NSAIDs has been reported in such aspirin-sensitive patients, celecoxib is contraindicated in patients with this form of aspirin sensitivity [seeContraindications (4)]. When celecoxib is used in patients with preexisting asthma (without known aspirin sensitivity), monitor patients for changes in the signs and symptoms of asthma.5.9 Serious Skin ReactionsSerious skin reactions have occurred following treatment with celecoxib, including erythema multiforme, exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalizedexanthematous pustulosis (AGEP). These serious events may occur without warning and can be fatal.Inform patients about the signs and symptoms of serious skin reactions, and to discontinue the use of celecoxib at the first appearance of skin rash or any other sign of hypersensitivity. Celecoxib is contraindicated in patients with previous serious skin reactions to NSAIDs [seeContraindications (4)].5.10 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Drug\\n\\nAnaphylactic ReactionsCelecoxib has been associated with anaphylactic reactions in patients with and without known hypersensitivity to celecoxib and in patients with aspirin sensitive asthma. Celecoxib is a sulfonamide and both NSAIDs and sulfonamides may cause allergic type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people [seeContraindications (4)andWarnings and Precautions (5.8)].Seek emergency help if any anaphylactic reaction occurs.5.8 Exacerbation of Asthma Related to Aspirin SensitivityA subpopulation of patients with asthma may have aspirin-sensitive asthma which may include chronic rhinosinusitis complicated by nasal polyps; severe, potentially fatal bronchospasm; and/or intolerance to aspirin and other NSAIDs. Because cross-reactivity between aspirin and other NSAIDs has been reported in such aspirin-sensitive patients, celecoxib is contraindicated in patients with this form of aspirin sensitivity [seeContraindications (4)]. When celecoxib is used in patients with preexisting asthma (without known aspirin sensitivity), monitor patients for changes in the signs and symptoms of asthma.5.9 Serious Skin ReactionsSerious skin reactions have occurred following treatment with celecoxib, including erythema multiforme, exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalizedexanthematous pustulosis (AGEP). These serious events may occur without warning and can be fatal.Inform patients about the signs and symptoms of serious skin reactions, and to discontinue the use of celecoxib at the first appearance of skin rash or any other sign of hypersensitivity. Celecoxib is contraindicated in patients with previous serious skin reactions to NSAIDs [seeContraindications (4)].5.10 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Drug', name='drugs', id='2a9760d5-89d5-41d9-bd58-9eef05baad16', tool_call_id='toolu_018QdcTpfrfMrbjSeDENfyAp')]}})\n",
      "(('doctor:a97bcf62-29c1-17a9-c8d8-9a80a49c4857',), {'agent': {'messages': [AIMessage(content=[{'text': 'Let me search for one more specific treatment option.', 'type': 'text'}, {'id': 'toolu_01EnAwRx41ZgKpJB3iZEvDJ5', 'input': {'query': 'inhaled corticosteroids ICS LABA asthma treatment'}, 'name': 'drugs', 'type': 'tool_use'}], additional_kwargs={}, response_metadata={'id': 'msg_016uchZjYpYFGBA5uyH7RNhe', 'model': 'claude-3-5-sonnet-20241022', 'stop_reason': 'tool_use', 'stop_sequence': None, 'usage': {'input_tokens': 4650, 'output_tokens': 77}}, id='run-0e6f2937-3d2a-424c-8732-8c3e306504b9-0', tool_calls=[{'name': 'drugs', 'args': {'query': 'inhaled corticosteroids ICS LABA asthma treatment'}, 'id': 'toolu_01EnAwRx41ZgKpJB3iZEvDJ5', 'type': 'tool_call'}], usage_metadata={'input_tokens': 4650, 'output_tokens': 77, 'total_tokens': 4727, 'input_token_details': {}})]}})\n",
      "(('doctor:a97bcf62-29c1-17a9-c8d8-9a80a49c4857',), {'tools': {'messages': [ToolMessage(content='respiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022', name='drugs', id='7ade52e1-e0b9-4b0a-aab7-7dd4be754b9e', tool_call_id='toolu_01EnAwRx41ZgKpJB3iZEvDJ5')]}})\n",
      "(('doctor:a97bcf62-29c1-17a9-c8d8-9a80a49c4857',), {'agent': {'messages': [AIMessage(content=\"Based on standard asthma treatment guidelines, when a patient fails to respond to Cromolyn Sodium Inhalation Solution, the next logical step in treatment would be to initiate or step up to inhaled corticosteroids (ICS). Here's the rationale and recommendation:\\n\\n1. Cromolyn Sodium is considered a mast cell stabilizer and is typically used as a controller medication for mild persistent asthma. It's not one of the primary controller medications in current asthma guidelines.\\n\\n2. The next logical step would be to:\\n- Start with a low-dose inhaled corticosteroid (ICS) as the preferred initial controller therapy\\n- If the patient is already on ICS, consider increasing the dose or adding a long-acting beta-agonist (LABA) in combination with ICS\\n\\n3. The specific choice would depend on:\\n- The severity of the patient's symptoms\\n- Their current level of control\\n- Their age\\n- Their ability to use the prescribed inhaler correctly\\n\\n4. If the patient shows no improvement with the initial ICS therapy, the next steps might include:\\n- Increasing the ICS dose\\n- Adding a LABA in combination with ICS\\n- Consider adding other controllers such as leukotriene modifiers\\n\\nIt's important to note that when making any medication changes:\\n- The patient's inhaler technique should be reviewed\\n- Adherence to the medication regimen should be assessed\\n- Environmental triggers should be evaluated and addressed\\n- A written asthma action plan should be provided or updated\\n\\nRegular follow-up should be scheduled to monitor the patient's response to the new treatment regimen.\", additional_kwargs={}, response_metadata={'id': 'msg_01QPfLBzAapdMJcczw2jSoeP', 'model': 'claude-3-5-sonnet-20241022', 'stop_reason': 'end_turn', 'stop_sequence': None, 'usage': {'input_tokens': 6701, 'output_tokens': 363}}, id='run-d8302bc6-5fb3-4319-afdc-1f8eafeb0ad9-0', usage_metadata={'input_tokens': 6701, 'output_tokens': 363, 'total_tokens': 7064, 'input_token_details': {}})]}})\n",
      "((), {'doctor': {'messages': [HumanMessage(content='After a patient fails to respond to Cromolyn Sodium Inhalation Solution for asthama management, what would be the next logical step in treatment?', additional_kwargs={}, response_metadata={}, id='0e7b15a0-129a-47a8-b2db-e0d506bd5aec'), AIMessage(content=[{'text': 'Let me search for information about Cromolyn Sodium and asthma treatment options to provide you with a comprehensive answer.', 'type': 'text'}, {'id': 'toolu_01HECLcgmhNBnJtkymMNnCdf', 'input': {'query': 'Cromolyn Sodium asthma treatment failure next step'}, 'name': 'drugs', 'type': 'tool_use'}], additional_kwargs={}, response_metadata={'id': 'msg_01Ravwq6Pe6ekyWwngq4ERym', 'model': 'claude-3-5-sonnet-20241022', 'stop_reason': 'tool_use', 'stop_sequence': None, 'usage': {'input_tokens': 445, 'output_tokens': 90}}, id='run-dc60300c-872b-496b-9717-b90456055af4-0', tool_calls=[{'name': 'drugs', 'args': {'query': 'Cromolyn Sodium asthma treatment failure next step'}, 'id': 'toolu_01HECLcgmhNBnJtkymMNnCdf', 'type': 'tool_call'}], usage_metadata={'input_tokens': 445, 'output_tokens': 90, 'total_tokens': 535, 'input_token_details': {}}), ToolMessage(content='respiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022', name='drugs', id='632730f0-5034-40da-93ff-19dc2bdf3a99', tool_call_id='toolu_01HECLcgmhNBnJtkymMNnCdf'), AIMessage(content=[{'text': 'Let me search for additional information about asthma treatment steps.', 'type': 'text'}, {'id': 'toolu_018QdcTpfrfMrbjSeDENfyAp', 'input': {'query': 'inhaled corticosteroids asthma treatment'}, 'name': 'drugs', 'type': 'tool_use'}], additional_kwargs={}, response_metadata={'id': 'msg_01VKhZm4ua3XiuTecRSoExiM', 'model': 'claude-3-5-sonnet-20241022', 'stop_reason': 'tool_use', 'stop_sequence': None, 'usage': {'input_tokens': 2509, 'output_tokens': 75}}, id='run-155559f3-289c-4b80-bc5b-19e749c2faf8-0', tool_calls=[{'name': 'drugs', 'args': {'query': 'inhaled corticosteroids asthma treatment'}, 'id': 'toolu_018QdcTpfrfMrbjSeDENfyAp', 'type': 'tool_call'}], usage_metadata={'input_tokens': 2509, 'output_tokens': 75, 'total_tokens': 2584, 'input_token_details': {}}), ToolMessage(content='Anaphylactic ReactionsCelecoxib has been associated with anaphylactic reactions in patients with and without known hypersensitivity to celecoxib and in patients with aspirin sensitive asthma. Celecoxib is a sulfonamide and both NSAIDs and sulfonamides may cause allergic type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people [seeContraindications (4)andWarnings and Precautions (5.8)].Seek emergency help if any anaphylactic reaction occurs.5.8 Exacerbation of Asthma Related to Aspirin SensitivityA subpopulation of patients with asthma may have aspirin-sensitive asthma which may include chronic rhinosinusitis complicated by nasal polyps; severe, potentially fatal bronchospasm; and/or intolerance to aspirin and other NSAIDs. Because cross-reactivity between aspirin and other NSAIDs has been reported in such aspirin-sensitive patients, celecoxib is contraindicated in patients with this form of aspirin sensitivity [seeContraindications (4)]. When celecoxib is used in patients with preexisting asthma (without known aspirin sensitivity), monitor patients for changes in the signs and symptoms of asthma.5.9 Serious Skin ReactionsSerious skin reactions have occurred following treatment with celecoxib, including erythema multiforme, exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalizedexanthematous pustulosis (AGEP). These serious events may occur without warning and can be fatal.Inform patients about the signs and symptoms of serious skin reactions, and to discontinue the use of celecoxib at the first appearance of skin rash or any other sign of hypersensitivity. Celecoxib is contraindicated in patients with previous serious skin reactions to NSAIDs [seeContraindications (4)].5.10 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Drug\\n\\nAnaphylactic ReactionsCelecoxib has been associated with anaphylactic reactions in patients with and without known hypersensitivity to celecoxib and in patients with aspirin sensitive asthma. Celecoxib is a sulfonamide and both NSAIDs and sulfonamides may cause allergic type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people [seeContraindications (4)andWarnings and Precautions (5.8)].Seek emergency help if any anaphylactic reaction occurs.5.8 Exacerbation of Asthma Related to Aspirin SensitivityA subpopulation of patients with asthma may have aspirin-sensitive asthma which may include chronic rhinosinusitis complicated by nasal polyps; severe, potentially fatal bronchospasm; and/or intolerance to aspirin and other NSAIDs. Because cross-reactivity between aspirin and other NSAIDs has been reported in such aspirin-sensitive patients, celecoxib is contraindicated in patients with this form of aspirin sensitivity [seeContraindications (4)]. When celecoxib is used in patients with preexisting asthma (without known aspirin sensitivity), monitor patients for changes in the signs and symptoms of asthma.5.9 Serious Skin ReactionsSerious skin reactions have occurred following treatment with celecoxib, including erythema multiforme, exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalizedexanthematous pustulosis (AGEP). These serious events may occur without warning and can be fatal.Inform patients about the signs and symptoms of serious skin reactions, and to discontinue the use of celecoxib at the first appearance of skin rash or any other sign of hypersensitivity. Celecoxib is contraindicated in patients with previous serious skin reactions to NSAIDs [seeContraindications (4)].5.10 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Drug\\n\\nAnaphylactic ReactionsCelecoxib has been associated with anaphylactic reactions in patients with and without known hypersensitivity to celecoxib and in patients with aspirin sensitive asthma. Celecoxib is a sulfonamide and both NSAIDs and sulfonamides may cause allergic type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people [seeContraindications (4)andWarnings and Precautions (5.8)].Seek emergency help if any anaphylactic reaction occurs.5.8 Exacerbation of Asthma Related to Aspirin SensitivityA subpopulation of patients with asthma may have aspirin-sensitive asthma which may include chronic rhinosinusitis complicated by nasal polyps; severe, potentially fatal bronchospasm; and/or intolerance to aspirin and other NSAIDs. Because cross-reactivity between aspirin and other NSAIDs has been reported in such aspirin-sensitive patients, celecoxib is contraindicated in patients with this form of aspirin sensitivity [seeContraindications (4)]. When celecoxib is used in patients with preexisting asthma (without known aspirin sensitivity), monitor patients for changes in the signs and symptoms of asthma.5.9 Serious Skin ReactionsSerious skin reactions have occurred following treatment with celecoxib, including erythema multiforme, exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalizedexanthematous pustulosis (AGEP). These serious events may occur without warning and can be fatal.Inform patients about the signs and symptoms of serious skin reactions, and to discontinue the use of celecoxib at the first appearance of skin rash or any other sign of hypersensitivity. Celecoxib is contraindicated in patients with previous serious skin reactions to NSAIDs [seeContraindications (4)].5.10 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Drug\\n\\nAnaphylactic ReactionsCelecoxib has been associated with anaphylactic reactions in patients with and without known hypersensitivity to celecoxib and in patients with aspirin sensitive asthma. Celecoxib is a sulfonamide and both NSAIDs and sulfonamides may cause allergic type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people [seeContraindications (4)andWarnings and Precautions (5.8)].Seek emergency help if any anaphylactic reaction occurs.5.8 Exacerbation of Asthma Related to Aspirin SensitivityA subpopulation of patients with asthma may have aspirin-sensitive asthma which may include chronic rhinosinusitis complicated by nasal polyps; severe, potentially fatal bronchospasm; and/or intolerance to aspirin and other NSAIDs. Because cross-reactivity between aspirin and other NSAIDs has been reported in such aspirin-sensitive patients, celecoxib is contraindicated in patients with this form of aspirin sensitivity [seeContraindications (4)]. When celecoxib is used in patients with preexisting asthma (without known aspirin sensitivity), monitor patients for changes in the signs and symptoms of asthma.5.9 Serious Skin ReactionsSerious skin reactions have occurred following treatment with celecoxib, including erythema multiforme, exfoliative dermatitis, Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN), drug reaction with eosinophilia and systemic symptoms (DRESS), and acute generalizedexanthematous pustulosis (AGEP). These serious events may occur without warning and can be fatal.Inform patients about the signs and symptoms of serious skin reactions, and to discontinue the use of celecoxib at the first appearance of skin rash or any other sign of hypersensitivity. Celecoxib is contraindicated in patients with previous serious skin reactions to NSAIDs [seeContraindications (4)].5.10 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)Drug', name='drugs', id='2a9760d5-89d5-41d9-bd58-9eef05baad16', tool_call_id='toolu_018QdcTpfrfMrbjSeDENfyAp'), AIMessage(content=[{'text': 'Let me search for one more specific treatment option.', 'type': 'text'}, {'id': 'toolu_01EnAwRx41ZgKpJB3iZEvDJ5', 'input': {'query': 'inhaled corticosteroids ICS LABA asthma treatment'}, 'name': 'drugs', 'type': 'tool_use'}], additional_kwargs={}, response_metadata={'id': 'msg_016uchZjYpYFGBA5uyH7RNhe', 'model': 'claude-3-5-sonnet-20241022', 'stop_reason': 'tool_use', 'stop_sequence': None, 'usage': {'input_tokens': 4650, 'output_tokens': 77}}, id='run-0e6f2937-3d2a-424c-8732-8c3e306504b9-0', tool_calls=[{'name': 'drugs', 'args': {'query': 'inhaled corticosteroids ICS LABA asthma treatment'}, 'id': 'toolu_01EnAwRx41ZgKpJB3iZEvDJ5', 'type': 'tool_call'}], usage_metadata={'input_tokens': 4650, 'output_tokens': 77, 'total_tokens': 4727, 'input_token_details': {}}), ToolMessage(content='respiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022\\n\\nrespiratory tract infection, rash. (6.1)To report SUSPECTED ADVERSE REACTIONS, contact Micro Labs USA, Inc. at 1-855-839-8195 or FDA at 1-800-FDA-1088 orwww.fda.gov/medwatchDRUG INTERACTIONSDrugs that Interfere with Hemostasis (e.g. warfarin, aspirin, selective serotonin reuptake inhibitors [SSRIs]/serotonin norepinephrine reuptake inhibitors [SNRIs]):Monitor patients for bleeding who are concomitantly taking celecoxib with drugs that interfere with hemostasis. Concomitant use of celecoxib and analgesic doses of aspirin is not generally recommended. (7)Angiotensin Converting Enzyme (ACE)Inhibitors, Angiotensin Receptor Blockers (ARB), or Beta-Blockers: Concomitant use with celecoxib may diminish the antihypertensive effect of these drugs. Monitor blood pressure. (7)ACE Inhibitors and ARBs: Concomitant use with celecoxib in elderly, volume depleted, or those with renal impairment may result in deterioration of renal function. In such high risk patients, monitor for signs of worsening renal function. (7)Diuretics: NSAIDs can reduce natriuretic effect of furosemide and thiazide diuretics. Monitor patients to assure diuretic efficacy including antihypertensive effects. (7)Digoxin: Concomitant use with celecoxib can increase serum concentration and prolong half-life of digoxin. Monitor serum digoxin levels. (7)USE IN SPECIFIC POPULATIONSInfertility:NSAIDs are associated with reversible infertility. Consider withdrawal of celecoxib in women who have difficulties conceiving. (8.3)See 17 for PATIENT COUNSELING INFORMATION and Medication Guide.Revised: 3/2022', name='drugs', id='7ade52e1-e0b9-4b0a-aab7-7dd4be754b9e', tool_call_id='toolu_01EnAwRx41ZgKpJB3iZEvDJ5'), AIMessage(content=\"Based on standard asthma treatment guidelines, when a patient fails to respond to Cromolyn Sodium Inhalation Solution, the next logical step in treatment would be to initiate or step up to inhaled corticosteroids (ICS). Here's the rationale and recommendation:\\n\\n1. Cromolyn Sodium is considered a mast cell stabilizer and is typically used as a controller medication for mild persistent asthma. It's not one of the primary controller medications in current asthma guidelines.\\n\\n2. The next logical step would be to:\\n- Start with a low-dose inhaled corticosteroid (ICS) as the preferred initial controller therapy\\n- If the patient is already on ICS, consider increasing the dose or adding a long-acting beta-agonist (LABA) in combination with ICS\\n\\n3. The specific choice would depend on:\\n- The severity of the patient's symptoms\\n- Their current level of control\\n- Their age\\n- Their ability to use the prescribed inhaler correctly\\n\\n4. If the patient shows no improvement with the initial ICS therapy, the next steps might include:\\n- Increasing the ICS dose\\n- Adding a LABA in combination with ICS\\n- Consider adding other controllers such as leukotriene modifiers\\n\\nIt's important to note that when making any medication changes:\\n- The patient's inhaler technique should be reviewed\\n- Adherence to the medication regimen should be assessed\\n- Environmental triggers should be evaluated and addressed\\n- A written asthma action plan should be provided or updated\\n\\nRegular follow-up should be scheduled to monitor the patient's response to the new treatment regimen.\", additional_kwargs={}, response_metadata={'id': 'msg_01QPfLBzAapdMJcczw2jSoeP', 'model': 'claude-3-5-sonnet-20241022', 'stop_reason': 'end_turn', 'stop_sequence': None, 'usage': {'input_tokens': 6701, 'output_tokens': 363}}, id='run-d8302bc6-5fb3-4319-afdc-1f8eafeb0ad9-0', usage_metadata={'input_tokens': 6701, 'output_tokens': 363, 'total_tokens': 7064, 'input_token_details': {}})]}})\n",
      "((), {'supervisor': {'next': '__end__'}})\n"
     ]
    }
   ],
   "source": [
    "for s in graph.stream(\n",
    "    {\"messages\": [(\"user\", \"After a patient fails to respond to Cromolyn Sodium Inhalation Solution for asthama management, what would be the next logical step in treatment?\")]}, subgraphs=True\n",
    "):\n",
    "    print(s)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "from dotenv import load_dotenv\n",
    "from langgraph.graph import StateGraph, START, END\n",
    "from langchain_groq import ChatGroq\n",
    "from langchain_core.messages import HumanMessage\n",
    "from typing import Literal\n",
    "from typing_extensions import TypedDict\n",
    "from dataclasses import dataclass\n",
    "from langgraph.graph import MessagesState\n",
    "\n",
    "# Load environment variables\n",
    "load_dotenv(\"./secrets/secrets.env\")\n",
    "groq_api_key = os.getenv(\"GROQ_API_KEY\")\n",
    "\n",
    "# Initialize the single LLM (ChatGroq)\n",
    "llm = ChatGroq(groq_api_key=groq_api_key, model_name=\"llama-3.2-3b-preview\")\n",
    "\n",
    "# Define State Schema\n",
    "@dataclass\n",
    "class AgentState(MessagesState):\n",
    "    \"\"\"State for multi-agent processing.\"\"\"\n",
    "    next: str = None\n",
    "\n",
    "class Router(TypedDict):\n",
    "    \"\"\"Worker to route to next. If no workers needed, route to FINISH.\"\"\"\n",
    "    next: Literal[\"question_answering\", \"recommendation\", \"alternatives\", \"summarization\", \"FINISH\"]\n",
    "\n",
    "# Supervisor Node\n",
    "def supervisor_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Determine the next worker node based on the query and current state.\"\"\"\n",
    "    system_prompt = (\n",
    "        \"You are a supervisor responsible for coordinating tasks among the following workers: question_answering, recommendation, alternatives, and summarization. \"\n",
    "        \"If the query asks for factual information, select 'question_answering'. \"\n",
    "        \"If the query requires advice, select 'recommendation'. \"\n",
    "        \"If the query asks for substitutes, select 'alternatives'. \"\n",
    "        \"If the query requires summarization, select 'summarization'. \"\n",
    "        \"Respond with the name of the next worker, or 'FINISH' if no further tasks are required. \"\n",
    "        \"Valid responses are: question_answering, recommendation, alternatives, summarization, FINISH. \"\n",
    "        \"IMPORTANT: Respond with only one of these names, without any additional text or explanation.\"\n",
    "    )\n",
    "\n",
    "    messages = [{\"role\": \"system\", \"content\": system_prompt}] + state[\"messages\"]\n",
    "\n",
    "    try:\n",
    "        response = llm.invoke(messages)\n",
    "        print(\"Supervisor response:\", response.content)  # Debugging: Print response\n",
    "\n",
    "        # Preprocess response\n",
    "        response_text = response.content.strip().lower()\n",
    "        response_text = response_text.split(\":\")[-1].strip()  # Handle verbose responses\n",
    "\n",
    "        # Validate response\n",
    "        if response_text in [\"question_answering\", \"recommendation\", \"alternatives\", \"summarization\", \"finish\"]:\n",
    "            state[\"next\"] = response_text\n",
    "            print(f\"Supervisor selected: {state['next']}\")  # Debugging: Print selected worker\n",
    "        else:\n",
    "            raise ValueError(f\"Unexpected response from supervisor: {response_text}\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in supervisor_node: {e}\")\n",
    "        raise RuntimeError(f\"Supervisor failed: {e}\")\n",
    "\n",
    "    return state\n",
    "\n",
    "# Worker Nodes\n",
    "def question_answering_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Handles question answering based on user query.\"\"\"\n",
    "    print(f\"Entering question_answering_node with state: {state}\")\n",
    "    \n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        response = llm.invoke([{\"role\": \"user\", \"content\": f\"Answer the following question:\\n{query}\"}])\n",
    "        if hasattr(response, \"content\") and response.content:\n",
    "            state[\"messages\"].append(HumanMessage(content=response.content, name=\"question_answering\"))\n",
    "            print(f\"Question answered: {response.content}\")\n",
    "        else:\n",
    "            raise ValueError(\"Invalid response from LLM in question_answering_node.\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in question_answering_node: {e}\")\n",
    "        raise RuntimeError(f\"Question answering failed: {e}\")\n",
    "\n",
    "    state[\"next\"] = \"FINISH\"\n",
    "    return state\n",
    "\n",
    "def recommendation_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Provides recommendations based on user query using LLM.\"\"\"\n",
    "    print(f\"Entering recommendation_node with state: {state}\")\n",
    "\n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        # Query the LLM for a recommendation\n",
    "        response = llm.invoke([{\"role\": \"user\", \"content\": f\"Provide a recommendation based on the following query:\\n{query}\"}])\n",
    "        if hasattr(response, \"content\") and response.content:\n",
    "            recommendation = response.content.strip()\n",
    "            state[\"messages\"].append(HumanMessage(content=recommendation, name=\"recommendation\"))\n",
    "            print(f\"Recommendation provided by LLM: {recommendation}\")\n",
    "        else:\n",
    "            raise ValueError(\"Invalid or empty response from LLM.\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in recommendation_node: {e}\")\n",
    "        raise RuntimeError(f\"Recommendation generation failed: {e}\")\n",
    "\n",
    "    state[\"next\"] = \"FINISH\"\n",
    "    return state\n",
    "\n",
    "\n",
    "def alternatives_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Suggests alternative medications dynamically using LLM.\"\"\"\n",
    "    print(f\"Entering alternatives_node with state: {state}\")\n",
    "\n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        # Query the LLM for alternatives\n",
    "        response = llm.invoke([{\"role\": \"user\", \"content\": f\"Suggest alternative medications for the following query:\\n{query}\"}])\n",
    "        if hasattr(response, \"content\") and response.content:\n",
    "            alternatives = response.content.strip()\n",
    "            state[\"messages\"].append(HumanMessage(content=alternatives, name=\"alternatives\"))\n",
    "            print(f\"Alternatives suggested by LLM: {alternatives}\")\n",
    "        else:\n",
    "            raise ValueError(\"Invalid or empty response from LLM.\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in alternatives_node: {e}\")\n",
    "        raise RuntimeError(f\"Alternatives generation failed: {e}\")\n",
    "\n",
    "    state[\"next\"] = \"FINISH\"\n",
    "    return state\n",
    "\n",
    "\n",
    "def summarization_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Summarizes the details provided in the user query using LLM.\"\"\"\n",
    "    print(f\"Entering summarization_node with state: {state}\")\n",
    "\n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        # Query the LLM for summarization\n",
    "        response = llm.invoke([{\"role\": \"user\", \"content\": f\"Please summarize the following details:\\n{query}\"}])\n",
    "        if hasattr(response, \"content\") and response.content:\n",
    "            summary = response.content.strip()\n",
    "            state[\"messages\"].append(HumanMessage(content=summary, name=\"summarization\"))\n",
    "            print(f\"Summary provided by LLM: {summary}\")\n",
    "        else:\n",
    "            raise ValueError(\"Invalid or empty response from LLM.\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in summarization_node: {e}\")\n",
    "        raise RuntimeError(f\"Summarization generation failed: {e}\")\n",
    "\n",
    "    state[\"next\"] = \"FINISH\"\n",
    "    return state\n",
    "\n",
    "# Conditional Edge Function\n",
    "def determine_next_worker(state: AgentState) -> str:\n",
    "    \"\"\"Determine the next worker to invoke based on the supervisor's decision.\"\"\"\n",
    "    return state.get(\"next\", END)\n",
    "\n",
    "# Build the State Graph\n",
    "def build_graph():\n",
    "    \"\"\"Constructs the state graph for the workflow.\"\"\"\n",
    "    builder = StateGraph(AgentState)\n",
    "    builder.add_node(\"supervisor\", supervisor_node)\n",
    "    builder.add_node(\"question_answering\", question_answering_node)\n",
    "    builder.add_node(\"recommendation\", recommendation_node)\n",
    "    builder.add_node(\"alternatives\", alternatives_node)\n",
    "    builder.add_node(\"summarization\", summarization_node)\n",
    "\n",
    "    builder.add_edge(START, \"supervisor\")\n",
    "    builder.add_conditional_edges(\"supervisor\", determine_next_worker)\n",
    "    return builder.compile()\n",
    "\n",
    "# Main Function\n",
    "def main():\n",
    "    \"\"\"Executes the workflow with example queries.\"\"\"\n",
    "    graph = build_graph()\n",
    "    queries = [\n",
    "        \"What are the uses of Amoxicillin?\",\n",
    "        \"Can I take Ibuprofen if I have stomach ulcers?\",\n",
    "        \"Suggest alternatives for Ibuprofen.\",\n",
    "        \"Summarize the details of Paracetamol.\"\n",
    "    ]\n",
    "\n",
    "    for query in queries:\n",
    "        print(f\"\\nProcessing query: {query}\")\n",
    "        state = AgentState(messages=[{\"role\": \"user\", \"content\": query}])\n",
    "\n",
    "        # Execute the graph for the current query\n",
    "        try:\n",
    "            for result in graph.stream(state, subgraphs=True):\n",
    "                print(result)\n",
    "                # Stop the loop after processing the query\n",
    "                if state.get(\"next\") == \"FINISH\":\n",
    "                    print(\"Workflow complete for this query.\\n---\")\n",
    "                    break\n",
    "        except Exception as e:\n",
    "            print(f\"Error while processing query: {query}. Error: {e}\")\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    main()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 152,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "from dotenv import load_dotenv\n",
    "from langgraph.graph import StateGraph, START, END\n",
    "from langchain_groq import ChatGroq\n",
    "from langchain_core.messages import HumanMessage\n",
    "from langchain.tools.retriever import create_retriever_tool\n",
    "from langchain_community.vectorstores import Chroma\n",
    "from langchain_ollama import OllamaEmbeddings\n",
    "from typing import Literal\n",
    "from typing_extensions import TypedDict\n",
    "from dataclasses import dataclass\n",
    "from langgraph.graph import MessagesState\n",
    "\n",
    "# Load environment variables\n",
    "load_dotenv(\"./secrets/secrets.env\")\n",
    "groq_api_key = os.getenv(\"GROQ_API_KEY\")\n",
    "\n",
    "# Initialize the LLM\n",
    "llm = ChatGroq(groq_api_key=groq_api_key, model_name=\"llama-3.2-3b-preview\")\n",
    "\n",
    "# Persistent directory for ChromaDB\n",
    "PERSIST_DIR = \"./db2\"\n",
    "\n",
    "# Initialize Chroma vectorstore\n",
    "embd = OllamaEmbeddings(model=\"nomic-embed-text\")\n",
    "# vectorstore = Chroma(persist_directory=PERSIST_DIR, embedding_function=embd)\n",
    "# retriever = vectorstore.as_retriever()\n",
    "\n",
    "# Create the retriever tool\n",
    "retriever_tool = create_retriever_tool(\n",
    "    retriever,\n",
    "    name=\"drugs\",\n",
    "    description=\"Search and return information about drugs\",\n",
    ")\n",
    "\n",
    "# Define State Schema\n",
    "@dataclass\n",
    "class AgentState(MessagesState):\n",
    "    \"\"\"State for multi-agent processing.\"\"\"\n",
    "    next: str = None\n",
    "\n",
    "class Router(TypedDict):\n",
    "    \"\"\"Worker to route to next. If no workers needed, route to FINISH.\"\"\"\n",
    "    next: Literal[\"retrieval\", \"question_answering\", \"recommendation\", \"alternatives\", \"summarization\", \"FINISH\"]\n",
    "\n",
    "# Supervisor Node\n",
    "def supervisor_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Determine the next worker node based on the query and current state.\"\"\"\n",
    "    system_prompt = (\n",
    "        \"You are a supervisor responsible for coordinating tasks among the following workers:  question_answering, recommendation, alternatives, and summarization. \"\n",
    "        # \"If the query requires factual retrieval, select 'retrieval'. \"\n",
    "        \"If the query asks for substitutes, select 'alternatives'. \"\n",
    "        \"If the query requires summarization, select 'summarization'. \"\n",
    "        \"Respond with the name of the next worker, or 'FINISH' if no further tasks are required.\"\n",
    "    )\n",
    "\n",
    "    messages = [{\"role\": \"system\", \"content\": system_prompt}] + state[\"messages\"]\n",
    "\n",
    "    try:\n",
    "        response = llm.invoke(messages)\n",
    "        print(\"Supervisor response:\", response.content)  # Debugging: Print response\n",
    "\n",
    "        # Preprocess response\n",
    "        response_text = response.content.strip().lower()\n",
    "        response_text = response_text.split(\":\")[-1].strip()  # Handle verbose responses\n",
    "\n",
    "        # Validate response\n",
    "        if response_text in [\"question_answering\", \"recommendation\", \"alternatives\", \"summarization\", \"finish\"]:\n",
    "            state[\"next\"] = response_text\n",
    "            print(f\"Supervisor selected: {state['next']}\")  # Debugging: Print selected worker\n",
    "        else:\n",
    "            raise ValueError(f\"Unexpected response from supervisor: {response_text}\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in supervisor_node: {e}\")\n",
    "        raise RuntimeError(f\"Supervisor failed: {e}\")\n",
    "\n",
    "    return state\n",
    "\n",
    "# Retrieval Node\n",
    "def retrieval_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Handles factual retrieval from the vectorstore.\"\"\"\n",
    "    print(f\"Entering retrieval_node with state: {state}\")\n",
    "\n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        # Use the retriever tool for the query\n",
    "        results = retriever.get_relevant_documents(query)\n",
    "        # print(results)\n",
    "        if results:\n",
    "            content = \"\\n\\n\".join([f\"Content:\\n{res.page_content}\\nMetadata: {res.metadata}\" for res in results])\n",
    "            state[\"messages\"].append(HumanMessage(content=content, name=\"retrieval\"))\n",
    "            print(f\"Retrieved documents:\\n{content}\")\n",
    "        else:\n",
    "            state[\"messages\"].append(HumanMessage(content=\"No relevant documents found.\", name=\"retrieval\"))\n",
    "    except Exception as e:\n",
    "        print(f\"Error in retrieval_node: {e}\")\n",
    "        raise RuntimeError(f\"Retrieval failed: {e}\")\n",
    "\n",
    "    # state[\"next\"] = \"FINISH\"\n",
    "    return state\n",
    "\n",
    "# Question Answering Node\n",
    "def question_answering_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Handles question answering based on user query.\"\"\"\n",
    "    print(f\"Entering question_answering_node with state: {state}\")\n",
    "    \n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        context = retriever.get_relevant_documents(query)\n",
    "        response = llm2.invoke([{\"role\": \"user\", \"content\": f\"Using the Context {context}, Answer the following question:\\n{query}\"}])\n",
    "        if hasattr(response, \"content\") and response.content:\n",
    "            state[\"messages\"].append(HumanMessage(content=response.content, name=\"question_answering\"))\n",
    "            print(f\"Question answered: {response.content}\")\n",
    "        else:\n",
    "            raise ValueError(\"Invalid response from LLM in question_answering_node.\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in question_answering_node: {e}\")\n",
    "        raise RuntimeError(f\"Question answering failed: {e}\")\n",
    "\n",
    "    state[\"next\"] = \"FINISH\"\n",
    "    return state\n",
    "\n",
    "# Recommendation Node\n",
    "def recommendation_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Provides recommendations based on user query using LLM.\"\"\"\n",
    "    print(f\"Entering recommendation_node with state: {state}\")\n",
    "\n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        context = retriever.get_relevant_documents(query)\n",
    "        response = llm.invoke([{\"role\": \"user\", \"content\": f\"Using the Context {context}, Answer the following question:\\n{query}\"}])\n",
    "        if hasattr(response, \"content\") and response.content:\n",
    "            recommendation = response.content.strip()\n",
    "            state[\"messages\"].append(HumanMessage(content=recommendation, name=\"recommendation\"))\n",
    "            print(f\"Recommendation provided by LLM: {recommendation}\")\n",
    "        else:\n",
    "            raise ValueError(\"Invalid or empty response from LLM.\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in recommendation_node: {e}\")\n",
    "        raise RuntimeError(f\"Recommendation generation failed: {e}\")\n",
    "\n",
    "    state[\"next\"] = \"FINISH\"\n",
    "    return state\n",
    "\n",
    "# Alternatives Node\n",
    "def alternatives_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Suggests alternative medications dynamically using LLM.\"\"\"\n",
    "    print(f\"Entering alternatives_node with state: {state}\")\n",
    "\n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        context = retriever.get_relevant_documents(query)\n",
    "        response = llm.invoke([{\"role\": \"user\", \"content\": f\"Using the Context {context}, Answer the following question:\\n{query}\"}])\n",
    "        if hasattr(response, \"content\") and response.content:\n",
    "            alternatives = response.content.strip()\n",
    "            state[\"messages\"].append(HumanMessage(content=alternatives, name=\"alternatives\"))\n",
    "            print(f\"Alternatives suggested by LLM: {alternatives}\")\n",
    "        else:\n",
    "            raise ValueError(\"Invalid or empty response from LLM.\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in alternatives_node: {e}\")\n",
    "        raise RuntimeError(f\"Alternatives generation failed: {e}\")\n",
    "\n",
    "    state[\"next\"] = \"FINISH\"\n",
    "    return state\n",
    "\n",
    "# Summarization Node\n",
    "def summarization_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Summarizes the details provided in the user query using LLM.\"\"\"\n",
    "    print(f\"Entering summarization_node with state: {state}\")\n",
    "\n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        context = retriever.get_relevant_documents(query)\n",
    "        response = llm.invoke([{\"role\": \"user\", \"content\": f\"Using the Context {context}, Answer the following question:\\n{query}\"}])\n",
    "        if hasattr(response, \"content\") and response.content:\n",
    "            summary = response.content.strip()\n",
    "            state[\"messages\"].append(HumanMessage(content=summary, name=\"summarization\"))\n",
    "            print(f\"Summary provided by LLM: {summary}\")\n",
    "        else:\n",
    "            raise ValueError(\"Invalid or empty response from LLM.\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in summarization_node: {e}\")\n",
    "        raise RuntimeError(f\"Summarization generation failed: {e}\")\n",
    "\n",
    "    state[\"next\"] = \"FINISH\"\n",
    "    return state\n",
    "\n",
    "# Conditional Edge Function\n",
    "def determine_next_worker(state: AgentState) -> str:\n",
    "    \"\"\"Determine the next worker to invoke based on the supervisor's decision.\"\"\"\n",
    "    return state.get(\"next\", END)\n",
    "\n",
    "# Build the State Graph\n",
    "def build_graph():\n",
    "    \"\"\"Constructs the state graph for the workflow.\"\"\"\n",
    "    builder = StateGraph(AgentState)\n",
    "    builder.add_node(\"supervisor\", supervisor_node)\n",
    "    builder.add_node(\"retrieval\", retrieval_node)\n",
    "    builder.add_node(\"question_answering\", question_answering_node)\n",
    "    builder.add_node(\"recommendation\", recommendation_node)\n",
    "    builder.add_node(\"alternatives\", alternatives_node)\n",
    "    builder.add_node(\"summarization\", summarization_node)\n",
    "\n",
    "    builder.add_edge(START, \"supervisor\")\n",
    "    builder.add_conditional_edges(\"supervisor\", determine_next_worker)\n",
    "    return builder.compile()\n",
    "\n",
    "# Main Function\n",
    "def main():\n",
    "    \"\"\"Executes the workflow with example queries.\"\"\"\n",
    "    graph = build_graph()\n",
    "    queries = [\n",
    "        \"What are the uses of Amoxicillin?\",\n",
    "        # \"Aspirin.\",\n",
    "        # \"Suggest alternatives for Ibuprofen.\",\n",
    "        # \"Summarize the details of Paracetamol.\"\n",
    "    ]\n",
    "\n",
    "    for query in queries:\n",
    "        print(f\"\\nProcessing query: {query}\")\n",
    "        state = AgentState(messages=[{\"role\": \"user\", \"content\": query}])\n",
    "\n",
    "        # Execute the graph for the current query\n",
    "        try:\n",
    "            for result in graph.stream(state, subgraphs=True):\n",
    "                print(result)\n",
    "                # Stop the loop after processing the query\n",
    "                if state.get(\"next\") == \"FINISH\":\n",
    "                    print(\"Workflow complete for this query.\\n---\")\n",
    "                    break\n",
    "        except Exception as e:\n",
    "            print(f\"Error while processing query: {query}. Error: {e}\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 153,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Processing query: What are the uses of Amoxicillin?\n",
      "Supervisor response: Since the query asks for substitutes, I will select 'alternatives'. \n",
      "\n",
      "Please pass the query to the 'alternatives' worker.\n",
      "Error in supervisor_node: Unexpected response from supervisor: since the query asks for substitutes, i will select 'alternatives'. \n",
      "\n",
      "please pass the query to the 'alternatives' worker.\n",
      "Error while processing query: What are the uses of Amoxicillin?. Error: Supervisor failed: Unexpected response from supervisor: since the query asks for substitutes, i will select 'alternatives'. \n",
      "\n",
      "please pass the query to the 'alternatives' worker.\n"
     ]
    }
   ],
   "source": [
    "main()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 111,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[]"
      ]
     },
     "execution_count": 111,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "retriever.get_relevant_documents('aspirin')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 154,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "Processing query: What are the uses of Amoxicillin?\n",
      "Supervisor response: retrieval\n",
      "Supervisor selected: retrieval\n",
      "((), {'supervisor': {'messages': [HumanMessage(content='What are the uses of Amoxicillin?', additional_kwargs={}, response_metadata={}, id='26877ffa-3791-4f7f-a9e1-f878c54e8a5a')], 'next': 'retrieval'}})\n",
      "Entering retrieval_node with state: {'messages': [HumanMessage(content='What are the uses of Amoxicillin?', additional_kwargs={}, response_metadata={}, id='26877ffa-3791-4f7f-a9e1-f878c54e8a5a')], 'next': 'retrieval'}\n",
      "((), {'retrieval': {'messages': [HumanMessage(content='What are the uses of Amoxicillin?', additional_kwargs={}, response_metadata={}, id='26877ffa-3791-4f7f-a9e1-f878c54e8a5a'), HumanMessage(content='No relevant documents found.', additional_kwargs={}, response_metadata={}, name='retrieval')], 'next': 'retrieval'}})\n",
      "\n",
      "Processing query: Retrieve details about Aspirin.\n",
      "Supervisor response: Next worker: question_answering\n",
      "Supervisor selected: question_answering\n",
      "((), {'supervisor': {'messages': [HumanMessage(content='Retrieve details about Aspirin.', additional_kwargs={}, response_metadata={}, id='1a1cabaa-9ad4-487d-a911-f04f014bf251')], 'next': 'question_answering'}})\n",
      "Entering question_answering with state: {'messages': [HumanMessage(content='Retrieve details about Aspirin.', additional_kwargs={}, response_metadata={}, id='1a1cabaa-9ad4-487d-a911-f04f014bf251')], 'next': 'question_answering'}\n",
      "Question_answering result: Aspirin, also known as acetylsalicylic acid (ASA), is a widely used medication that belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). Here are some key details about Aspirin:\n",
      "\n",
      "**Origin and History**: Aspirin was first synthesized in 1853 by French chemist Charles Frederic Gerhardt. However, it wasn't until 1899 that it was commercialized by Bayer, a German pharmaceutical company.\n",
      "\n",
      "**Mechanism of Action**: Aspirin works by inhibiting the production of prostaglandins, which are hormone-like substances that cause pain, inflammation, and fever. It does this by blocking the enzyme cyclooxygenase (COX), which is responsible for converting arachidonic acid into prostaglandins.\n",
      "\n",
      "**Medical Uses**: Aspirin is primarily used to:\n",
      "\n",
      "1. **Relieve Pain**: Aspirin is effective in reducing pain caused by headaches, toothaches, and menstrual cramps.\n",
      "2. **Reduce Inflammation**: It is used to treat conditions like arthritis, sprains, and strains.\n",
      "3. **Lower Fever**: Aspirin is effective in reducing fever caused by infections.\n",
      "4. **Prevent Heart Attacks**: Low-dose aspirin is often prescribed to individuals at high risk of heart attacks to prevent blood clots from forming.\n",
      "\n",
      "**Side Effects**: Common side effects of aspirin include:\n",
      "\n",
      "1. **Stomach Upset**: Aspirin can irritate the stomach lining, leading to heartburn, nausea, and diarrhea.\n",
      "2. **Allergic Reactions**: Some individuals may be allergic to aspirin, which can cause hives, itching, and difficulty breathing.\n",
      "3. **Bleeding Risks**: Aspirin can increase the risk of bleeding, especially in individuals taking other medications that thin the blood.\n",
      "\n",
      "**Precautions**: Aspirin should be used with caution in certain individuals, including:\n",
      "\n",
      "1. **Children**: Aspirin can be toxic to children, especially those under the age of 18.\n",
      "2. **Pregnant or Breastfeeding Women**: Aspirin should be used only under the guidance of a healthcare professional in these situations.\n",
      "3. **Individuals with Bleeding Disorders**: Aspirin can worsen bleeding disorders like hemophilia.\n",
      "\n",
      "**Contraindications**: Aspirin is contraindicated in individuals with certain medical conditions, including:\n",
      "\n",
      "1. **Stomach Ulcers or Bleeding**: Aspirin can exacerbate stomach ulcers or bleeding.\n",
      "2. **Kidney or Liver Disease**: Aspirin can worsen kidney or liver disease.\n",
      "\n",
      "Overall, Aspirin is a widely used medication that can provide relief from pain, inflammation, and fever. However, it's essential to use it responsibly and follow the recommended dosage and precautions to minimize the risk of side effects.\n",
      "((), {'question_answering': {'messages': [HumanMessage(content='Retrieve details about Aspirin.', additional_kwargs={}, response_metadata={}, id='1a1cabaa-9ad4-487d-a911-f04f014bf251'), HumanMessage(content=\"Aspirin, also known as acetylsalicylic acid (ASA), is a widely used medication that belongs to the class of nonsteroidal anti-inflammatory drugs (NSAIDs). Here are some key details about Aspirin:\\n\\n**Origin and History**: Aspirin was first synthesized in 1853 by French chemist Charles Frederic Gerhardt. However, it wasn't until 1899 that it was commercialized by Bayer, a German pharmaceutical company.\\n\\n**Mechanism of Action**: Aspirin works by inhibiting the production of prostaglandins, which are hormone-like substances that cause pain, inflammation, and fever. It does this by blocking the enzyme cyclooxygenase (COX), which is responsible for converting arachidonic acid into prostaglandins.\\n\\n**Medical Uses**: Aspirin is primarily used to:\\n\\n1. **Relieve Pain**: Aspirin is effective in reducing pain caused by headaches, toothaches, and menstrual cramps.\\n2. **Reduce Inflammation**: It is used to treat conditions like arthritis, sprains, and strains.\\n3. **Lower Fever**: Aspirin is effective in reducing fever caused by infections.\\n4. **Prevent Heart Attacks**: Low-dose aspirin is often prescribed to individuals at high risk of heart attacks to prevent blood clots from forming.\\n\\n**Side Effects**: Common side effects of aspirin include:\\n\\n1. **Stomach Upset**: Aspirin can irritate the stomach lining, leading to heartburn, nausea, and diarrhea.\\n2. **Allergic Reactions**: Some individuals may be allergic to aspirin, which can cause hives, itching, and difficulty breathing.\\n3. **Bleeding Risks**: Aspirin can increase the risk of bleeding, especially in individuals taking other medications that thin the blood.\\n\\n**Precautions**: Aspirin should be used with caution in certain individuals, including:\\n\\n1. **Children**: Aspirin can be toxic to children, especially those under the age of 18.\\n2. **Pregnant or Breastfeeding Women**: Aspirin should be used only under the guidance of a healthcare professional in these situations.\\n3. **Individuals with Bleeding Disorders**: Aspirin can worsen bleeding disorders like hemophilia.\\n\\n**Contraindications**: Aspirin is contraindicated in individuals with certain medical conditions, including:\\n\\n1. **Stomach Ulcers or Bleeding**: Aspirin can exacerbate stomach ulcers or bleeding.\\n2. **Kidney or Liver Disease**: Aspirin can worsen kidney or liver disease.\\n\\nOverall, Aspirin is a widely used medication that can provide relief from pain, inflammation, and fever. However, it's essential to use it responsibly and follow the recommended dosage and precautions to minimize the risk of side effects.\", additional_kwargs={}, response_metadata={}, name='question_answering')], 'next': 'FINISH'}})\n",
      "\n",
      "Processing query: Suggest alternatives for Ibuprofen.\n",
      "Supervisor response: FINISH\n",
      "Supervisor selected: finish\n",
      "((), {'supervisor': {'messages': [HumanMessage(content='Suggest alternatives for Ibuprofen.', additional_kwargs={}, response_metadata={}, id='ad6a5744-aff8-4672-aa30-8f7d84742bf2')], 'next': 'finish'}})\n",
      "Error while processing query: Suggest alternatives for Ibuprofen.. Error: 'branch:supervisor:determine_next_worker:finish'\n",
      "\n",
      "Processing query: Summarize the details of Paracetamol.\n",
      "Supervisor response: summarization\n",
      "Supervisor selected: summarization\n",
      "((), {'supervisor': {'messages': [HumanMessage(content='Summarize the details of Paracetamol.', additional_kwargs={}, response_metadata={}, id='f796860e-c9e0-4f5d-96b2-8df9477bad22')], 'next': 'summarization'}})\n",
      "Entering summarization with state: {'messages': [HumanMessage(content='Summarize the details of Paracetamol.', additional_kwargs={}, response_metadata={}, id='f796860e-c9e0-4f5d-96b2-8df9477bad22')], 'next': 'summarization'}\n",
      "Summarization result: Paracetamol, also known as acetaminophen, is a widely used over-the-counter (OTC) pain reliever and fever reducer. Here are the key details about Paracetamol:\n",
      "\n",
      "**Composition:** Paracetamol is an analgesic (pain reliever) and antipyretic (fever reducer) medication that is chemically known as N-acetyl-p-aminophenol.\n",
      "\n",
      "**Uses:** It is used to relieve mild to moderate pain and reduce fever in adults and children.\n",
      "\n",
      "**Side Effects:** Common side effects include nausea, dizziness, and stomach upset. In rare cases, it can cause more serious side effects such as liver damage, allergic reactions, and kidney problems.\n",
      "\n",
      "**Dosage:** The recommended dosage of Paracetamol varies depending on age, weight, and the specific product being used. Typically, the recommended dose is 500-1000 mg every 4-6 hours.\n",
      "\n",
      "**Interactions:** Paracetamol can interact with other medications, such as blood thinners, and should be used with caution in people with certain medical conditions, such as liver or kidney disease.\n",
      "\n",
      "**Precautions:** It is not recommended for people with severe allergies, liver or kidney disease, or those taking certain medications, such as blood thinners.\n",
      "\n",
      "**Overdose:** Taking high doses of Paracetamol can lead to liver damage and even death. If someone has taken an overdose, it is essential to seek medical attention immediately.\n",
      "\n",
      "**Medical Conditions:** Paracetamol is not recommended for people with certain medical conditions, such as porphyria, a genetic disorder that can cause sensitivity to pain relievers.\n",
      "\n",
      "Overall, Paracetamol is a widely used medication for relief of pain and fever, but it should be used with caution and under the guidance of a healthcare professional.\n",
      "((), {'summarization': {'messages': [HumanMessage(content='Summarize the details of Paracetamol.', additional_kwargs={}, response_metadata={}, id='f796860e-c9e0-4f5d-96b2-8df9477bad22'), HumanMessage(content='Paracetamol, also known as acetaminophen, is a widely used over-the-counter (OTC) pain reliever and fever reducer. Here are the key details about Paracetamol:\\n\\n**Composition:** Paracetamol is an analgesic (pain reliever) and antipyretic (fever reducer) medication that is chemically known as N-acetyl-p-aminophenol.\\n\\n**Uses:** It is used to relieve mild to moderate pain and reduce fever in adults and children.\\n\\n**Side Effects:** Common side effects include nausea, dizziness, and stomach upset. In rare cases, it can cause more serious side effects such as liver damage, allergic reactions, and kidney problems.\\n\\n**Dosage:** The recommended dosage of Paracetamol varies depending on age, weight, and the specific product being used. Typically, the recommended dose is 500-1000 mg every 4-6 hours.\\n\\n**Interactions:** Paracetamol can interact with other medications, such as blood thinners, and should be used with caution in people with certain medical conditions, such as liver or kidney disease.\\n\\n**Precautions:** It is not recommended for people with severe allergies, liver or kidney disease, or those taking certain medications, such as blood thinners.\\n\\n**Overdose:** Taking high doses of Paracetamol can lead to liver damage and even death. If someone has taken an overdose, it is essential to seek medical attention immediately.\\n\\n**Medical Conditions:** Paracetamol is not recommended for people with certain medical conditions, such as porphyria, a genetic disorder that can cause sensitivity to pain relievers.\\n\\nOverall, Paracetamol is a widely used medication for relief of pain and fever, but it should be used with caution and under the guidance of a healthcare professional.', additional_kwargs={}, response_metadata={}, name='summarization')], 'next': 'FINISH'}})\n"
     ]
    }
   ],
   "source": [
    "import os\n",
    "from dotenv import load_dotenv\n",
    "from langgraph.graph import StateGraph, START, END\n",
    "from langchain_groq import ChatGroq\n",
    "from langchain_core.messages import HumanMessage\n",
    "from langchain.tools.retriever import create_retriever_tool\n",
    "from langchain_community.vectorstores import Chroma\n",
    "from langchain_ollama import OllamaEmbeddings\n",
    "from typing import Literal\n",
    "from typing_extensions import TypedDict\n",
    "from dataclasses import dataclass\n",
    "from langgraph.graph import MessagesState\n",
    "\n",
    "# Load environment variables\n",
    "load_dotenv(\"./secrets/secrets.env\")\n",
    "groq_api_key = os.getenv(\"GROQ_API_KEY\")\n",
    "\n",
    "# Initialize the LLM\n",
    "llm = ChatGroq(groq_api_key=groq_api_key, model_name=\"llama-3.2-3b-preview\")\n",
    "\n",
    "# Persistent directory for ChromaDB\n",
    "PERSIST_DIR = \"./db2\"\n",
    "\n",
    "# Initialize Chroma vectorstore\n",
    "embd = OllamaEmbeddings(model=\"nomic-embed-text\")\n",
    "vectorstore = Chroma(persist_directory=PERSIST_DIR, embedding_function=embd)\n",
    "retriever = vectorstore.as_retriever()\n",
    "\n",
    "# Create the retriever tool\n",
    "retriever_tool = create_retriever_tool(\n",
    "    retriever,\n",
    "    name=\"drugs\",\n",
    "    description=\"Search and return information about drugs\",\n",
    ")\n",
    "\n",
    "# Define State Schema\n",
    "@dataclass\n",
    "class AgentState(MessagesState):\n",
    "    \"\"\"State for multi-agent processing.\"\"\"\n",
    "    next: str = None\n",
    "\n",
    "class Router(TypedDict):\n",
    "    \"\"\"Worker to route to next. If no workers needed, route to FINISH.\"\"\"\n",
    "    next: Literal[\"retrieval\", \"question_answering\", \"recommendation\", \"alternatives\", \"summarization\", \"FINISH\"]\n",
    "\n",
    "# Supervisor Node\n",
    "def supervisor_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Determine the next worker node based on the query and current state.\"\"\"\n",
    "    system_prompt = (\n",
    "        \"You are a supervisor responsible for coordinating tasks among the following workers: retrieval, question_answering, recommendation, alternatives, and summarization. \"\n",
    "        \"If the query requires factual retrieval, select 'retrieval'. \"\n",
    "        \"If the query asks for substitutes, select 'alternatives'. \"\n",
    "        \"If the query requires summarization, select 'summarization'. \"\n",
    "        \"Respond with the name of the next worker, or 'FINISH' if no further tasks are required.\"\n",
    "    )\n",
    "\n",
    "    messages = [{\"role\": \"system\", \"content\": system_prompt}] + state[\"messages\"]\n",
    "\n",
    "    try:\n",
    "        response = llm.invoke(messages)\n",
    "        print(\"Supervisor response:\", response.content)  # Debugging: Print response\n",
    "\n",
    "        # Preprocess response\n",
    "        response_text = response.content.strip().lower()\n",
    "        response_text = response_text.split(\":\")[-1].strip()  # Handle verbose responses\n",
    "\n",
    "        # Validate response\n",
    "        if response_text in [\"retrieval\", \"question_answering\", \"recommendation\", \"alternatives\", \"summarization\", \"finish\"]:\n",
    "            state[\"next\"] = response_text\n",
    "            print(f\"Supervisor selected: {state['next']}\")  # Debugging: Print selected worker\n",
    "        else:\n",
    "            raise ValueError(f\"Unexpected response from supervisor: {response_text}\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in supervisor_node: {e}\")\n",
    "        raise RuntimeError(f\"Supervisor failed: {e}\")\n",
    "\n",
    "    return state\n",
    "\n",
    "# Worker Nodes\n",
    "def retrieval_node(state: AgentState) -> AgentState:\n",
    "    \"\"\"Handles factual retrieval from the vectorstore.\"\"\"\n",
    "    print(f\"Entering retrieval_node with state: {state}\")\n",
    "\n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        results = retriever.get_relevant_documents(query)\n",
    "        if results:\n",
    "            content = \"\\n\\n\".join([f\"Content:\\n{res.page_content}\\nMetadata: {res.metadata}\" for res in results])\n",
    "            state[\"messages\"].append(HumanMessage(content=content, name=\"retrieval\"))\n",
    "            print(f\"Retrieved documents:\\n{content}\")\n",
    "        else:\n",
    "            state[\"messages\"].append(HumanMessage(content=\"No relevant documents found.\", name=\"retrieval\"))\n",
    "    except Exception as e:\n",
    "        print(f\"Error in retrieval_node: {e}\")\n",
    "        raise RuntimeError(f\"Retrieval failed: {e}\")\n",
    "\n",
    "    return state\n",
    "\n",
    "def generic_worker_node(state: AgentState, task_name: str) -> AgentState:\n",
    "    \"\"\"Handles a generic worker task.\"\"\"\n",
    "    print(f\"Entering {task_name} with state: {state}\")\n",
    "\n",
    "    if state[\"messages\"]:\n",
    "        query = state[\"messages\"][-1].content\n",
    "    else:\n",
    "        query = \"\"\n",
    "\n",
    "    try:\n",
    "        context_docs = retriever.get_relevant_documents(query)\n",
    "        context = \"\\n\".join([doc.page_content for doc in context_docs])\n",
    "\n",
    "        response = llm.invoke([{\"role\": \"user\", \"content\": f\"Context: {context}\\nTask: {task_name}\\nQuery: {query}\"}])\n",
    "        if hasattr(response, \"content\") and response.content:\n",
    "            state[\"messages\"].append(HumanMessage(content=response.content.strip(), name=task_name))\n",
    "            print(f\"{task_name.capitalize()} result: {response.content.strip()}\")\n",
    "        else:\n",
    "            raise ValueError(f\"Invalid or empty response from LLM in {task_name}.\")\n",
    "    except Exception as e:\n",
    "        print(f\"Error in {task_name}: {e}\")\n",
    "        raise RuntimeError(f\"{task_name.capitalize()} failed: {e}\")\n",
    "\n",
    "    state[\"next\"] = \"FINISH\"\n",
    "    return state\n",
    "\n",
    "# Specific Worker Nodes\n",
    "def question_answering_node(state: AgentState) -> AgentState:\n",
    "    return generic_worker_node(state, \"question_answering\")\n",
    "\n",
    "def recommendation_node(state: AgentState) -> AgentState:\n",
    "    return generic_worker_node(state, \"recommendation\")\n",
    "\n",
    "def alternatives_node(state: AgentState) -> AgentState:\n",
    "    return generic_worker_node(state, \"alternatives\")\n",
    "\n",
    "def summarization_node(state: AgentState) -> AgentState:\n",
    "    return generic_worker_node(state, \"summarization\")\n",
    "\n",
    "# Conditional Edge Function\n",
    "def determine_next_worker(state: AgentState) -> str:\n",
    "    \"\"\"Determine the next worker to invoke based on the supervisor's decision.\"\"\"\n",
    "    return state.get(\"next\", END)\n",
    "\n",
    "# Build the State Graph\n",
    "def build_graph():\n",
    "    \"\"\"Constructs the state graph for the workflow.\"\"\"\n",
    "    builder = StateGraph(AgentState)\n",
    "    builder.add_node(\"supervisor\", supervisor_node)\n",
    "    builder.add_node(\"retrieval\", retrieval_node)\n",
    "    builder.add_node(\"question_answering\", question_answering_node)\n",
    "    builder.add_node(\"recommendation\", recommendation_node)\n",
    "    builder.add_node(\"alternatives\", alternatives_node)\n",
    "    builder.add_node(\"summarization\", summarization_node)\n",
    "\n",
    "    builder.add_edge(START, \"supervisor\")\n",
    "    builder.add_conditional_edges(\"supervisor\", determine_next_worker)\n",
    "    return builder.compile()\n",
    "\n",
    "# Main Function\n",
    "def main():\n",
    "    \"\"\"Executes the workflow with example queries.\"\"\"\n",
    "    graph = build_graph()\n",
    "    queries = [\n",
    "        \"What are the uses of Amoxicillin?\",\n",
    "        \"Retrieve details about Aspirin.\",\n",
    "        \"Suggest alternatives for Ibuprofen.\",\n",
    "        \"Summarize the details of Paracetamol.\"\n",
    "    ]\n",
    "\n",
    "    for query in queries:\n",
    "        print(f\"\\nProcessing query: {query}\")\n",
    "        state = AgentState(messages=[{\"role\": \"user\", \"content\": query}])\n",
    "\n",
    "        # Execute the graph for the current query\n",
    "        try:\n",
    "            for result in graph.stream(state, subgraphs=True):\n",
    "                print(result)\n",
    "                if state.get(\"next\") == \"FINISH\":\n",
    "                    print(\"Workflow complete for this query.\\n---\")\n",
    "                    break\n",
    "        except Exception as e:\n",
    "            print(f\"Error while processing query: {query}. Error: {e}\")\n",
    "\n",
    "\n",
    "if __name__ == \"__main__\":\n",
    "    main()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "llm_hackathon",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.12.7"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
